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Abstract
Background: Successful diabetes disease management involves routine medical care with individualized patient goals,
self-management education and on-going support to reduce complications. Without interventions that facilitate patient
scheduling, improve attendance to provider appointments and provide patient information to provider and care team,
preventive services cannot begin. This review examines interventions based upon three focus areas: 1) scheduling the
patient with their provider; 2) getting the patient to their appointment, and; 3) having patient information integral to their
diabetes care available to the provider. This study identifies interventions that improve appointment management and
preparation as well as patient clinical and behavioral outcomes.
Methods: A systematic review of the literature was performed using MEDLINE, CINAHL and the Cochrane library. Only
articles in English and peer-reviewed articles were chosen. A total of 77 articles were identified that matched the three
focus areas of the literature review: 1) on the schedule, 2) to the visit, and 3) patient information. These focus areas were
utilized to analyze the literature to determine intervention trends and identify those with improved diabetes clinical and
behavioral outcomes.
Results: The articles included in this review were published between 1987 and 2013, with 46 of them published after 2006.
Forty-two studies considered only Type 2 diabetes, 4 studies considered only Type 1 diabetes, 15 studies considered both
Type 1 and Type 2 diabetes, and 16 studies did not mention the diabetes type. Thirty-five of the 77 studies in the review
were randomized controlled studies. Interventions that facilitated scheduling patients involved phone reminders, letter
reminders, scheduling when necessary while monitoring patients, and open access scheduling. Interventions used to
improve attendance were letter reminders, phone reminders, short message service (SMS) reminders, and financial
incentives. Interventions that enabled routine exchange of patient information included web-based programs, phone calls,
SMS, mail reminders, decision support systems linked to evidence-based treatment guidelines, registries integrated with
electronic medical records, and patient health records.
Conclusions: The literature review showed that simple phone and letter reminders for scheduling or prompting of the
date and time of an appointment to more complex web-based multidisciplinary programs with patient self-management
can have a positive impact on clinical and behavioral outcomes for diabetes patients. Multifaceted interventions aimed at
appointment management and preparation during various phases of the medical outpatient care process improves
diabetes disease management.
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Background
Diabetes is a complex chronic illness with significant
health and financial implications. It has risen to epidemic
proportions in the United States affecting approximately
26 million individuals in 2010 [1]. Projections reveal that
if the current increase in diabetes incidence persists and
diabetes mortality remains relatively low, prevalence will
increase from the current level of 8.3 to 33 % of the
adult population by 2050 [2]. Estimates indicate that the
United States spent $218 billion in costs for pre-diabetes
and diabetes care in 2007 [3]. The American Diabetes
Association (ADA) and Healthy People 2020 propose
guidelines and objectives for effective diabetes care man-
agement to reduce the incidence and economic burden of
diabetes [4, 5]. These objectives purport routine medical
care with goals and treatment plans individualized for
each patient, self-management education and on-going
support to reduce the risk of diabetic complications [4].
According to ADA guidelines, which may vary from year
to year based on evidence, people with diabetes should
receive diabetes self-management education (DSME) at the
time their diabetes is diagnosed and as needed thereafter.
HbA1c test should be performed at least 2 times a year.
The fasting lipid profile (total cholesterol, LDL, HDL,
triglycerides) should be measured at least annually. A
routine urinalysis and microalbuminuria test should be
performed annually to assess nephropathy. A comprehen-
sive foot exam should be performed every year to identify
risk factors for ulcers and amputations. A dilated eye exam
is recommended every year. Flu vaccines should be pro-
vided annually to all patients with diabetes. Pneumococcal
vaccines are recommended for all patients over 2 years
old. Self-monitoring of blood glucose (SMBG) should be
performed three or more times a day for patients using
multiple insulin injections or insulin pump therapy.
The percentage of United States adults with diabetes
who received preventive care practices in 2009–2010 were
as follows: ever attended diabetes self-management class,
57.4 %; check HbA1c ≥ 2 times a year, 68.5 %; annual foot
exam, 67.5 %; annual eye exam, 62.8 %; annual flu vaccine,
50.1 %, and; daily self-monitor of blood glucose, 63.6 %
[6]. Many factors including demographic, psychological,
social, disease, treatment, provider, organizational, and
care delivery related factors contribute to poor adherence
[7]. These low levels of preventive care suggest an oppor-
tunity to enhance adherence to guidelines for effective
disease management through appointment management
and preparation because before diabetes preventive care
practices can be instituted, patients must first be sched-
uled for and attend their provider appointments. There-
fore, this study focuses on organizational and care delivery
system related factors that relate to appointment manage-
ment, as well as regular monitoring of relevant patient
information integral to disease management.
Routine medical care starts with scheduling the pa-
tient with the provider for preventive care services. The
patient can be scheduled for the next visit immediately
after a provider visit or at a later time when the patient
requests an appointment by phone or electronically.
Interventions that proactively schedule the patient with
their provider are a necessity for timely treatment deci-
sions. Once patients are scheduled for their provider
appointments the next step is to ensure that they at-
tend their appointments. Studies show that no-show
rates for diabetic patients vary from 4 to 40 % [8].
Literature also indicates that diabetic patients with
higher no-show rates have poorer outcomes e.g., higher
glycosylated hemoglobin (HbA1c) levels and poorer
glycemic control than patients who attend appoint-
ments [8]. Without interventions to encourage patients
to schedule and attend their provider appointments,
other multifactorial interventions to reduce diabetes
complications and costs of care cannot be initiated.
Research indicates that diabetes patients actively in-
volved in their self-management experience improved
Quality of Life (QOL) and improved HbA1c levels [9, 10].
Currently, most diabetes care is provided in primary care
practices. Accomplishing diabetes care objectives during
fifteen to twenty minute appointments can be challenging
for primary care providers. A provider cannot prepare
individualized patient care without important patient
information regarding self-monitoring blood glucoses
(SMBG), daily diet and nutrition, exercise or physical
activity, and medication information and compliance. To
aid in the process of effective disease management,
patients must take an informed and active role in the
process. Interventions that aid the patient in communi-
cating this information to the provider would expedite
patient care delivery and allow the provider more time
for individualization of the patient’s treatment plan and
patient support in self-management.
Literature examining interventions in diabetes care is ex-
tensive and offers a wide variability in types of interventions
ranging from medication to web-based self-management
tools with varying impact on diabetes outcomes. Different
from the earlier literature reviews, the purpose of this litera-
ture review is to evaluate interventions that apply to ap-
pointment management and preparation, and determine
their impact on appointment, clinical and behavioral out-
comes for diabetic patients. This review examines inter-
ventions based upon three focus areas: 1) scheduling
the patient with their provider; 2) getting the patient to
their appointment, and; 3) having patient information
integral to their diabetes care available to the provider.
The hypothesis of this study is that interventions, which
improve appointment management and preparation, are
significantly associated with favorable appointment, clin-
ical and behavioral outcomes.
Nuti et al. BMC Health Services Research  (2015) 15:355 Page 2 of 54
Methods
Data source
This literature review was completed in February 2014.
MEDLINE, the PubMed interface, was the primary data-
base utilized. The following combination of MeSH terms
was used for the search: “Diabetes Mellitus”[Mesh] AND
(“Intervention Studies”[Mesh] OR “Internet”[Mesh] OR
“Reminder Systems”[Mesh] OR “Appointments and
Schedules”[Mesh] OR “Patient-Centered Care”[Mesh]
OR “Registries”[Mesh] OR “Guideline Adherence”[Mesh])
NOT (“Diabetes, Gestational”[Mesh] OR “Pharmacolo-
gical Processes”[Mesh] OR “Pharmacological Phenomena”
[Mesh] OR “Transplantation”[Mesh] OR “Cardiovascular
Surgical Procedures” [Mesh] OR “Heart Diseases”[Mesh]
OR “Incidence”[Mesh]). Additionally, the reference lists
of included articles and literature reviews were also
examined for additional relevant articles. We searched
CINAHL and found no additional articles. The Cochrane
database was also searched and did not reveal other
systematic reviews on this topic.
The search inclusion criteria for the intervention articles
were: 1) outpatient diabetes mellitus; 2) adults; and 3) Eng-
lish. The search exclusion criteria eliminated the following
types of articles: 1) gestational diabetes; 2) pharmaco-
logical processes and phenomena; 3) transplantation
(surgery); 4) cardiovascular surgical procedures; 5) heart
diseases; and 6) incidence.
Data extraction
The comprehensive literature search generated 4111 articles
(See Fig. 1). Studies excluding gestational, pharmacological
process, pharmacological phenomena, transplantation, car-
diovascular procedures, heart diseases and incidence re-
duced potential relevant articles to 2810. Articles were
limited to those involving adults (19+ per PubMed), written
in English and containing an abstract, which further reduced
the total to 1308. Two reviewers reviewed the abstracts in-
dependently. All possible articles that could not be excluded
were recorded in a table. Each study was marked as “rele-
vant”, “not relevant”, or “maybe” based on the provided in-
formation in the paper and the goals for this systematic
review. Once the reviewers prepared the tables independ-
ently, the decisions were compared and discussed in a meet-
ing. Disagreement regarding inclusion of the article was
reconciled through discussion with all other authors. Finally,
by excluding articles that were not related to evaluation of
Fig. 1 PRISMA flow chart of article selection process
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an implemented intervention, the sample was reduced to
211 articles. Full texts of the 211 articles were retrieved and
outcomes were evaluated independently by two reviewers
according to structural, process, and outcomes measures
[11]. One hundred and thirty four articles were excluded be-
cause they did not relate to the three focus areas: 1) on the
schedule, 2) to the visit, and 3) patient information; the
remaining 77 articles were included in this literature review.
Disagreements regarding interpretation of data extracted
from articles were reconciled through discussion with the
authors. However, description of the types of interventions
and outcomes were summarized and trended.
Results
The articles included in this review were published be-
tween 1987 and 2013, with 46 of them published after
2006. The following is a list of countries and the num-
ber of studies from that country included in the review:
United States (43); South Korea (15); Netherlands (4);
United Kingdom (3); Canada (3); Australia (2); France
(1); Finland (1); Iran (1); Italy (1); Norway (1); Taiwan
(1) and; Turkey (1). Thirty-five of the 77 studies in the
review were randomized controlled studies.
Table 1 is a summary of study designs and interven-
tions used in each article included in this literature re-
view. Appendix 1 provides detailed information about
the interventions that focus on three areas of diabetes
outpatient care delivery system: 1) scheduling the patient
with their provider; 2) getting the patient to their ap-
pointment, and; 3) having patient information integral to
their diabetes care available to the provider.
The reviewed articles evaluated the impact of interven-
tions on several outcome measures. We divided the
outcome measures into two types: clinical outcomes and
behavioral outcomes. Clinical outcomes include the value
of laboratory test results such as HbA1c, LDL, HDL, sys-
tolic blood pressure (SBP), diastolic blood pressure (DBP),
total cholesterol, triglycerides, fasting plasma glucose, cre-
atinine, 2-hour post meal glucose, and the value of clinical
measures such as weight and body mass index (BMI).
Given the importance of HbA1c in diabetes care, Table 2
includes only HbA1c results. All other clinical outcomes
are provided in Appendix 2. In Table 2 and Appendix 2,
we present the difference between the clinical outcome
value at baseline and after the intervention (e.g., HbA1c
at baseline – HbA1c at m months after the interven-
tion) for both intervention and control groups. Where
available, the p-values are presented for the difference
between groups and the difference within the groups.
The behavioral outcomes, summarized in Appendix 3,
include measures related to self-management (SMBG test-
ing, physical activity, foot care, diet, nutrition, self-efficacy,
quality of life, and patient satisfaction), attendance to out-
patient visits for laboratory tests, vaccinations, primary
care and specialty care, adherence to ADA guidelines
(annual foot exam, annual eye exam, and processes of
care), and acute care utilization (emergency visits, and
hospital admissions). Since different measures or tools are
used in different studies, we did not provide the numerical
values for the changes in outcomes. For example, patient
satisfaction is measured using different survey tools. The
attendance to laboratory visits are measured using the
number of laboratory tests within the next 6 months or
12 months after the intervention, or the percentage of
patients who had the recommended laboratory tests
within a year. For adherence to recommended laboratory
tests, we included the tests considered in that study, and
for vaccinations we presented the vaccinations.
In Tables 3, 4, and 5, we summarize the primary out-
comes from the studies in Table 2, Appendix 2, and
Appendix 3, based on if the interventions were directed
at getting patients on the schedule, to the visit, or with
the necessary patient information, respectively. Refer-
ence numbers of studies with significant outcome find-
ings are bolded. In the following sections, we describe
the most notable findings from these studies.
On the schedule
For the purpose of this literature review, an intervention that
enables a patient to schedule a provider appointment or la-
boratory test meets criteria for ‘on the schedule’. Review of
the literature found limited research studying scheduling in-
terventions as compared to diabetes intervention research
pertaining to communication of patient information to the
provider. The scheduling interventions, summarized in
Table 3, included sending reminders to schedule a provider
appointment or laboratory test, scheduling when necessary
while monitoring patient information, and open access
scheduling to provide same-day access. Although phone re-
minders were found to be effective for the most part to in-
crease patient attended appointments, impact on clinic
outcomes, as with other interventions in this focus group,
were mixed and only a few studies discussed proactive ap-
pointment scheduling or management.
Grassroots interventions such as letter and phone re-
minders have been used to remind diabetic patients to
schedule a provider appointment or a laboratory test. While
the letter reminder, which asked the patients to call and
make an appointment, improve the clinical outcomes in-
cluding HbA1c, and SBP significantly in one study [12], it
was not very effective in improving the clinical outcomes in
other studies [13]. In a RCT, a letter from the provider was
mailed to patients prior to their birthday with a self-care
handbook, preventive care checklist and recommendations
for routine monitoring and screening resulting in a signifi-
cantly increased percentage of patients with an HbA1c test,
percentage of patients with one diabetes-related provider
visit, and percentage of patients with an eye exam within 6
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Table 1 Summary of study designs and interventions
Author Diabetes type Study population Methodology Intervention
1 Anderson et al.
2003 [15]
98.5 % of intervention group
patients are Type 2; 100 % of control
group patients are Type 2
nI = 67, nC = 65; African Americans; Patients
with normal or mild eye exam; Detroit
metropolitan area; United States (US).
Randomized Control Trial (RCT);
Measurement: 12 months (mos).
Letter and phone reminder
2 Austin and Wolfe
2011 [24]
Not given nI = 464, nC = 693; without HbA1c or LDL-C
prior 12 mos; Midwestern university system;
US.
Quasi-experimental; Measurement: 12 mos. Letter reminder with a
financial incentive
3 Avdal et al. 2011 [61] Type 2 nI = 61, nC = 61; diagnosis at least 6 mos,
> 18 yrs old, on insulin, HbA1c > 7 %,
completed diabetes education, can use
computer and internet, and volunteered
to participate; Turkey.
RCT; Measurements: baseline and 6 mos. Web-based
Exclusion: advanced retinopathy or neuropathy.
4 Bailie et al. 2004 [62] Type 2 nB = 137, n6 = 137, n1 = 133, n2 = 123, n3 = 146;
Aboriginal people, Australia.
Follow-up study over 3 years;
Measurements: baseline, 6 mos, and
year 1, 2, and 3.
Electronic Health Record
(EHR); Evidence-based
Guidelines
5 Benhamou et al.
2007 [63]
Type 1 n = 30; ≥ 18 years old, on external insulin
pump for 3 mos, and HbA1c 7.5 %-10 %;
France.
Bicenter, open-label, randomized,
two-period crossover study; 6 mos with
SMS (short message service) followed by
6 mos without SMS or reverse sequence;
Measurements: baseline and two 6-month
periods.
Web-based; SMS
Exclusion: retinopathy, pregnancy, unable to
use software, out of mobile phone network,
or unwilling to do 4 SMBG tests/day.
6 Bond et al. 2006 [64] Not given n = 15; diabetes, age 60 or older; Washington,
US.
Randomized in the first phase, pilot study Web-based
7 Bond et al. 2007 [36] 87 % Type 1, 13 % Type 2 nI = 31;nC = 31; ≥ 60 years old; having
diagnosed with diabetes for at least 1 year,
living independently in the community,
fluency in English, West coast university
health system; US.
RCT; Randomized using two-tier strata
(above and below 7.5 % HbA1c) and
gender. Intervention subjects participated
in one of two phases (each phase lasting
one year); Measurements: baseline and
6 mos.
Web-based; Behavioral
Exclusion: mod/severe cognitive, visual, or
physical impairment or severe co-morbid
disease.
8 Carter et al. 2011 [37] Type 2 nI = 26, nC = 21; type 2 diabetes 2 yrs prior
to study, ≥ 18 yrs old, African American,
8th grade reading level, residing in
Washington, DC, willing provider; US.
RCT; Measurements: baseline and 9 mos. Web-based; Behavioral
Exclusion: visually or hearing impaired,
non-English speaking, on dialysis or
psychotropic meds.
9 Cavan et al. 2003 [65] Type 1 n = 6; type 1 diabetes and attended one-hour
training session; United Kingdom
Pilot study; Measurements: baseline,
3 and 6 mos, and year 1 and 2.
Web-based
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Table 1 Summary of study designs and interventions (Continued)
10 Cherry et al. 2002 [46] Not given n = 169; indigent or economically disadvantaged
adults, competent, have telephone, can read or
have reading assistance, reside and have
physician in Mercy Health Center, Laredo, TX
service area; US.
Cohort; Measurements: baseline, quarterly
for 2 quarters and 12 mos.
Web-based; Telephone data
line; Behavioral
11 Cho et al. 2006 [57] Type 2 nI = 40, nC = 40; ≥ 30 yrs old, > 6 mos in center;
South Korea.
Prospective, RCT; Measurements: baseline,
3-month intervals up to 30 mos.
Web-based
Exclusion: disabling conditions, severe diabetes
complications, intensified insulin regimen, no
internet access, unwilling, or in similar programs.
12 Cho et al. 2009 [66] Type 2 Internet: n = 37; diabetes phone: n = 38; internet
access and uses mobile phone/SMS; South Korea.
Randomized, non-inferiority with active-
controlled period; Measurements: baseline
to 3 mos.
Diabetes Phone; Web-based;
SMS
Exclusion: heart failure, liver enzymes 2x normal,
renal disease (creatinine > 1.5 mg/dL), in similar
programs.
13 Cho et al. 2011 [67] Type 2 nI = 35, nc = 36; age ≥ 40; HbA1c from 7.0 to
11.0 %; followed at least 6 months in a public
healthcare post in rural areas of Chung-ju, Korea.
RCT; Measurements: Baseline and at
3 months.
Web-based; Phone call;
Performance feedback
Exclusion: diagnosed or suspected disease of
liver, pancreas, endocrine organ, kidney; ischemic
heart disease; cerebrovascular disease; creatinine
>0.133 mmol/l; intensive insulin regimen; unable
to attend regularly.
14 Chumbler et al.
2005 [21]
Not given nI = 400, nC = 400; ≥ 2 Veterans Administration
(VA) hospitalizations or emergency visits in last
year, telephone access, non-institutionalized;
Florida, Puerto Rico and Georgia; US.
Retrospective, concurrent matched cohort;
Measurements: 12 mos before and after.
Web-based; Telephone
data line
15 Ciemins et al.
2009 [52]
Not given n = 495; adult, provider visit in last year; central/
eastern Montana and northern Wyoming; US.
Pre-post intervention, cohort; Measurements:
2 year baseline and two consecutive 2 year
intervention periods.
EHR; Registry; Patient and
provider report cards;
Evidence-based guidelines
Exclusion: gestational or steroid-induced
diabetes, nursing home resident, prednisone
use > 2 mos, or seen by endocrinologist for
care and testing.
16 de Grauw et al.
2002 [19]
Type 2 n = 432 baseline, n = 594 follow-up; type 2
diabetes; Nijmegen Academic Research Network,
the Netherlands.
Multicenter cross-sectional; Measurements:
baseline and 6 yrs.
Registry; Phone reminder
17 Derose et al.
2009 [25]
Type 1 or 2 (based on ICD-9 codes) nI.1 = 2916, nI.2 = 1934, nI.3 = 1933, nI.4 = 2199,
nI.5 = 2200, nC = 1875; no HbA1c, LDL-C, and
urinary microalbumin tests in > 1 yr, and birthday
in 3 mos; Southern California Kaiser Permanent; US.
RCT; Measurements: 2 consecutive 3-month
periods.
Letter and phone reminder
18 Dijkstra et al.
2005 [54]
32 % of intervention group
patients are Type 1, 33 % of control
group patients are Type 1
nI = 351, nC = 418 patients; nI = 4 nC = 5 hospitals;
nI = 22, nC = 20 internists; the Netherlands.
Clustered, RCT; Measurements:
baseline and post-intervention
(time varied per indicator)
Patient-held record (PHR);
Evidence-based guidelines
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Table 1 Summary of study designs and interventions (Continued)
19 Edelman et al.
2010 [34]
Not given nI = 133, nC = 106; hypertension and diabetes,
on diabetes medication, HbA1c > 7.5 % and
systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg;
North Carolina and Virginia, US.
RCT; Measurements: study
midpoint (6.8 mos) and
completion (12.8 mos).
Financial incentive; Group
visit
Exclusion: seen by endocrine clinic in past 6 mos,
hospitalized for psychosis in past 3 yrs, cognitively
impaired, or severe chronic illness.
20 Edwards et al.
2012 [17]
Type 1 or 2 (based on ICD-9 codes) nI = 94, nC = 210; age 18 and 85 yrs; diabetes
patients who were scheduled for appointments
with a primary care provider between 08/2010
and 04/2011; University of Oklahoma Family
Medicine Center (FMC) in Oklahoma City, US.
RCT; Measurements: 1 year before the
intervention, and immediate at
intervention
Phone call; Evidence-based
guidelines
Exclusion: pregnant; recently seen in group
visits; diabetes managed by a provider outside
the FMC.
21 Farmer et al.
2005 [68]
Type 1 nI = 47, nC = 46; United Kingdom; age 18–30 yrs,
basal bolus insulin, last 2 HbA1c tests 8 -11 %.
RCT, parallel-group; Measurements:
baseline, 4 and 9 mos.
Web-based; SMS
Exclusion: avoid tight glycemic control, another
severe disease, cannot do SMBG, or other family
member in trial.
22 Fischer et al.
2011 [13]
Type 1 or 2 (based on ICD-9 codes) Mailed report cards: nI = 2728, nC = 2729;
Printable report cards: nI = 2357, nC = 3100;
Provider report cards: nI = 2893, nC = 2564;
>17 yrs, at least one visit to clinic within
18 mos; Denver, CO; US.
Nested randomized trial; Measurements:
baseline and 13 mos.
Registry; Patient and
provider report cards;
Mail reminder
Exclusion: >75 yrs, no mail address, cannot
speak English or Spanish
23 Fischer et al.
2012 [69]
Not given n = 47; age≥ 18 yrs; diabetes, have cell phone;
fluent in English or Spanish; regularly receive
healthcare at a federally qualified community
health center in Denver, Colorado, US.
Quasi-experimental; Measurement: at 3 mos. SMS; Phone call; Behavioral
24 Glasgow et al.
2003 [70]
Type 2 n = 320; live by self for ≥ 1 yr; have phone; read
and write English; diabetes for at least 1 yr and
not moving out of area next yr; Kaiser Colorado,
US.
RCT; 3 intervention groups: basic
information, tailored self-management
and peer support. Measurements: baseline
and 10 mos.
Web-based; Behavioral
25 Glasgow et al.
2004 [58]
Type 2 nI = 469, nC = 417 patients; nI = 24, nC = 28
physicians (all physicians in Diabetes Priority
Program); type 2 diabetes, ≥ 25 yrs old, can
read English; Colorado; US.
Two-group cluster, RCT; Measurements:
baseline and 6 mos.
Web-based
26 Grant et al. 2008 [55] Type 2 nI = 126 nC = 118 patients, n = 11 practices;
HbA1c > 7 % in prior yr, active diabetes
prescription, ≥ 1 visit within prior yr, active
account with patient web-portal; eastern
Massachusetts; US.
RCT; Measurements: baseline and 12 mos. Web-based
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Table 1 Summary of study designs and interventions (Continued)
27 Harno et al. 2006 [71] Type 1 or 2 nI = 101, nC = 74; type 1 or type 2 diabetes; 2
university hospital outpatient clinics; Finland.
RCT; Measurements: baseline and 12 mos. Web-based; SMS
28 Holbrook et al.
2009 [28]
Type 2 nI = 253, nC = 258; ≥ 18 yrs old, fluent in English
and able to understand the study description;
Ontario, Canada.
Pragmatic RCT; Measurements: baseline
and 6 mos.
Web-based; Phone reminder,
Behavioral
29 Hurwitz et al.
1993 [72]
Type 2 n = 187; non-insulin dependent diabetes mellitus,
≤ 80 yrs old, attend clinic≥ 2 yrs; United Kingdom.
RCT; Measurements: baseline and 2 yrs. Letter and phone reminder
Exclusion: women of childbearing age or
patients with significant diabetic complications.
30 Jones and Curry
2006 [50]
Type 2 nI = 58, nC = 115; 2 provider visits during study,
and≤ 1 provider visit in opposite group;
Pennsylvania; US
Non-randomized clinical trial; historical
control group; Measurements: baseline
and within 16 mos after intervention.
Personal digital assistant;
Provider reminder; Letter
reminder; Evidence-based
guidelines
31 HS Kim et al.
2005 [44]
Type 2 n = 42; able to do SBMG and self-injection of
medication, access to web sites and cellular
phone; South Korea.
Quasi-experimental, one group, pretest-
posttest; Measurements: baseline and
12 weeks.
Web-based; SMS
Exclusion: severe illness, renal insufficiency
(creatinine > 1.5 mg/dL) or on insulin pump.
32 HS Kim et al.
2006 [42]
Type 2 n = 33; ≥ 30 yrs old, can do SMBG tests and
medication injection, can input data to web,
internet access, and cellular phone; South Korea.
Quasi-experimental, one group, pretest-
posttest; Measurements: baseline and
12 weeks.
Web-based; SMS
Exclusion: heart failure, hepatic dysfunction,
renal insufficiency, on insulin pump or other
diabetes web offer.
33,
34
HS Kim 2007
[39, 40]
Type 2 nI = 25, nC = 26; able to do SBMG and self-
injection of medication, access to web sites
and cellular phone; South Korea.
Control group, pretest-posttest,
randomized by random permuted block
design; Measurements: baseline, and
3 mos.
Web-based; SMS; Behavioral
Exclusion: severe illness, renal insufficiency, or
on insulin pump.
35 HS Kim and
Jeong 2007 [41]
Type 2 nI = 25, nC = 26; able to do SBMG and self-
injection of medication, able to input data to
web site, had home internet access, and cellular
phone; South Korea.
Control group, pretest-posttest, randomized
by random permuted block design;
Measurements: baseline, 3, and 6 mos.
Web-based; SMS
Exclusion: severe illness, renal insufficiency, or
on insulin pump.
36 HS Kim and
Song 2008 [43]
Type 2 nI = 18, nC = 16; ≥ 30 yrs old, obese, able to do
SBMG and self-medication, able to input data
to web site, had home internet access, and
cellular phone; South Korea.
Quasi-experimental, repeated measures,
pretest-posttest; Measurements: baseline,
3, and 6 mos.
Web-based; SMS
Exclusion: heart failure, hepatic dysfunction,
renal insufficiency, or on insulin pump.
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Table 1 Summary of study designs and interventions (Continued)
37 SI Kim and
HS Kim 2008 [73]
Type 2 nI = 18, nC = 16; able to do SBMG and self-
injection of medication, access to web sites and
cellular phone; South Korea.
Quasi-experimental, repeated
measures, pretest-posttest;
Measurements: baseline, 3, 6, 9,
and 12 mos.
Web-based; SMS
Exclusion: severe illness, renal insufficiency, or
on insulin pump.
38 Kirsh et al. 2007 [12] Type 2 nI = 44, nC = 35; one or more of following:
A1c > 9 %, SBP >160 mm Hg and
LDL-c >130 mg/dl; Veterans Healthcare System;
US.
Quasi-experimental, non-randomized
concurrent controls; Measurements:
baseline and 6 mos
Letter reminder
39 Kwon et al. 2004 [74] Type 2 nI = 51, nC = 50; type 2 diabetes≥ 1 yr, internet
access, ≥ 30 yrs old; South Korea.
RCT; Measurements: baseline and 12 weeks. Web-based
Exclusion: significant diseases likely to affect
outcome (heart failure, hepatic dysfunction, renal
insufficiency or on insulin pump).
40 Kwon et al. 2004 [45] 16.2 % Type 1, 82.7 % Type 2,
1.1 % secondary diabetes
n = 185; diabetes≥ 1 yr, internet access; South
Korea.
Non-randomized cohort; Measurements:
baseline and 3 mos.
Web-based; SMS
Exclusion: significant diseases likely to affect
outcome (hepatic or renal failure).
41 Lafata et al. 2002 [14] Type 1 or 2 (based on ICD-9 codes) nI = 1641, nC = 1668; in patient registry, ≥ 18 yrs
and≥ 2 diabetes visits or at least 1 pharmacy
claim for diabetes drug in last 24 mos; Michigan,
US
RCT; Measurements: 6 and 12 mos. Letter reminder
42 Lin et al. 2007 [29] Not given nI = 33, nC = 35; Canadian primary care center. Historical cohort; Measurements: baseline
and 3 years.
Phone reminder; Evidence-
based guidelines; Longer
appointmentsExclusion: no family doctor and those without
at least 2 diabetic follow-up appointments.
43 Litzelman et al.
1993 [75]
Type 2 nI = 191, nC = 205; non-insulin dependent
diabetes, ≥ 2 visits in prior yr, > 40 yrs old,
diabetes diagnosis after age 30, 2 yrs with
practice, and ideal or heavier than ideal body
weight, at risk of lower-extremity amputation;
Indianapolis; US.
RCT; Measurements: baseline and 12 mos. Phone and postcard
reminder; Behavioral
Exclusion: pregnancy, major psychiatric illness,
dementia, terminal illness (death in 1 yr), renal
failure, bilateral amputations and investigator’s
patients.
44 Lorig et al. 2010 [76] Type 2 nI.1 = 209, nI.2 = 186, nI.3 = 395, nC = 238; aged
≥ 18 yrs, not pregnant or in cancer care,
physician verified type 2 diabetes diagnosis and
access to the Internet. Effort to recruit American
Indians/Alaskan Natives; California; US.
RCT; Measurements: baseline, 6, and
18 mos.
Web-based
45 Maclean et al.
2009 [20]
Type 1 or 2 nI = 3886, nC = 3526 patients; nI = 70, nC = 62
physicians; nI = 30, nC = 34 practices; HbA1c in
last 2 yrs; Vermont and New York; US.
RCT; Practices randomized in blocks by
hospital laboratory; Measurements: 32 mos.
Registry; Decision support;
Fax and Letter reminder
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Table 1 Summary of study designs and interventions (Continued)
Exclusion: < 18 yrs, cognitive impairment or
provider decision.
46 McCarrier et al.
2009 [77]
Type 1 nI = 41, nC = 36; 21–49 yrs old, ≥ 2 encounters
and at least 1 HbA1c in prior yr, recent HbA1c
>7% and reside in King or Snohomish County,
Center, Washington; US.
Randomized, pretest-posttest
trial; Measurements: 12 mos.
Web-based
47 McDermott et al.
2001 [32]
Not given n = 282 patients at 8 intervention sites, n = 396
patients at 13 control sites; mostly Torres Strait
Islanders, Australia
Randomized unblended, cluster trial;
Measurements: baseline and 12 mos.
Registry; Evidence based
guidelines
48 McDiarmid et al.
2001 [51]
Type 2 n = 258; urban family practice residency,
Greensboro, North Carolina; US.
Non-randomized, before/after, retrospective
chart audit; Measurements: baseline and
12 mos.
Evidence-based guidelines
49 McMahon et al.
2005 [78]
Not given nI = 52, nC = 52; HbA1c≥ 9 %, age > 18 yrs,
understands written and spoken English,
willingness to use notebook computer, glucose
and BP devices; Boston VA Healthcare System;
US.
RCT; Measurements: baseline, 3, 6, 9 and
12 mos.
Web-based
50 McMahon et al.
2012 [47]
Type 2 nI.1 = 51, nI.2 = 51, nI.3 = 49; age > 25 yrs,
HbA1c > 8.5 %, understand written and spoken
English, access to phone, willingness to use
laptop, and BP and glucose monitoring devices,
have a VA-based primary care provider; Boston,
MA; US.
RCT; Measurements: 3, 6, 9, and 12 mos. Web-based; Phone calls;
Performance feedback
51 Mehler et al.
2005 [79]
Type 2 nI.1 = 415, nI.2 = 146, nC = 323 patients at 12
primary care practices; age≥ 40 yrs; Denver-
metro area; US.
Stratified and randomized by practice
type (family medicine, internal medicine
or academic); Measurements: baseline and
15 mos.
Evidence-based guidelines
52 Meigs et al.
2003 [49]
Type 2 nI = 307 patients, nI = 12 providers; nC = 291
patients, nC = 14 providers; hospital-based
staff-resident medical practice; Boston,
Massachusetts; US.
RCT; Measurements: 12 mos pre-
intervention and 12 mos post-intervention.
Web-based; Decision
support; Evidence-based
guidelines
53 Meulepas et al.
2007 [30]
Type 2 nI = 353 patients, nI = 51 providers; nC = 129
patients, nC = 27 providers; documented
diabetes for > 4 yrs at start of study; The
Netherlands
Controlled, non-randomized, before/after
study with delayed intervention in control
group; Measurements: 1 yr before
intervention and 2 years after.
Phone reminder
54 Meulepas et al.
2008 [31]
Type 2 nI = 431 patients, nI = 23 providers; nC = 469
patients, nC = 28 providers; in the south of
The Netherlands
Controlled, non-randomized study, before/
after; Measurements: 1 yr before
intervention and 2 years after.
Phone reminder
55 Moattari et al.
2013 [80]
97 % Type 1 nI = 24, nC = 24; have diabetes, need insulin,
ability to use glucometer and inject insulin,
ability to input data on a website, own
cellphone; Shiraz, Iran.
RCT; Measurements: baseline and 3 mos. Web-based; Phone; SMS
Exclusion: chronic disease or renal failure
(creatinine > 1.5 mg/dl), use of insulin pump,
pregnancy.
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Table 1 Summary of study designs and interventions (Continued)
56 Moorman et al.
2012 [81]
Not given nC = 19, nI = 18; Adult diabetic patients
not working with a case manager, at
least one request for a self-monitoring
blood glucose log, Ohio, US
Cohort study; Measurements: 3 mos.
before the intervention and 3 mos. after.
Letter reminder
Exclusion: No documented mailing address
57 Musacchio et al.
2011 [82]
Type 2 n = 1004; HbA1c < 7 %, ability to follow
educational program, and clinical data for prior
12 mos; Italy.
Pre-post study; Measurements: baseline
and 12 mos.
Tele-medicine (phone and
internet); EHR; Behavioral
58 Nes et al. 2012 [83] Type 2 n = 11; type 2 diabetes, no other inclusion/
exclusion criteria reported; Oslo, Norway
Snowball sample pilot study; baseline and
3 mos.
Web-based; Performance
feedback
59 Piette et al. 2000 [84] Not given n = 248; English or Spanish speaking adults;
California; US.
Randomized control trial; Measurements:
baseline and 12 mos.
Automated phone call
Exclusion: >75 yrs, psychotic, sensory
impairment, or life expectancy <12 mos, on
hypoglycemic medication, diabetes≤ 6 mos,
plan to stop clinic services during study period,
no push-button phone.
60 Rai et al. 2011 [18] Type 1 or 2 (based on ICD-9 codes) nI = 1765, nC = 1315; 2 diabetes and hypertension
ICD-9 codes in billing data in past 2 yrs; no
provider visit in last 6 mos; Wisconsin; US.
Quasi-experimental; Measurement: 6 mos. Phone reminder
Exclusion: patient without history of treatment
by provider.
61 Ralston et al.
2009 [38]
Type 2 nI = 39, nC = 35; 18–75 yrs old, last HbA1c≥ 7 %,
at least two visits in prior year; University of
Washington; US.
Randomized, single-centered, controlled
trial with parallel group design;
Measurements: 12 mos before intervention
and 12 mos after.
Web-based; Decision
support
Exclusion: in pilot, psychological illness, non-
English speaking, resident as provider or mostly
specialty care.
62 Ryan et al. 2013 [85] Type 2 nI = 24; age 21 and older; established patient;
seen at least once for diabetes management
during the previous 12 months; Most recent
A1c < 10; last A1c within last 6 months; a
community health clinic in Miami, Florida, US.
Pretest-posttest; Measurements: baseline
and 13 mos.
Web-based
Exclusion: Did not speak English; had an
emergency room discharge or hospital admission
for a diabetes-related complication during the
6 months before recruitment; were homeless or
did not have control of the given living situation;
had significant cognitive impairment or
psychological distress; had known substance or
alcohol abuse.
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Table 1 Summary of study designs and interventions (Continued)
63 Sacco et al. 2009 [48] Type 2 nI = 31, nC = 31; age18 – 65 yrs, reads and speaks
English, reachable by phone, HbA1c > 6.5 %,
cardiovascular risk factor; Florida; US
Randomized, pretest-posttest;
Measurements: baseline and 6 mos.
Behavioral; Phone coaching
Exclusion: major medical/mental disorder.
64 Sadur et al. 1999 [22] Type 1 or 2 16-75 yrs old, recent HbA1c > 8.5 % or no HbA1c
in last year; Kaiser; California; US.
RCT; Measurements: baseline and 6 mos.
Hospitalization rate measured 12 mos
before intervention and 18 mos after.
Group visit; Phone;
Behavioral
Exclusion: pregnancy, dementia, no English,
cannot attend monthly meetings.
65 Seto et al. 2012 [16] Type 1 or 2 nI = 580; age 18 and older; seen at the health
center between July 1, 2009 and June 30, 2010;
a primary care clinic in San Jose, California, US.
Pretest-posttest; Measurements:
baseline and 7 mos.
Registry; Appointment
reminder
Exclusion: No baseline A1c; gestational diabetes
66 DM Smith et al.
1987 [27]
Not given nI = 425, nC = 429; patients with insulin or oral
hypoglycemic agents prescribed, reported all
care received at center, not residents of nursing
home or other institution, ≥ 15 yrs old, visited
clinic in last yr and had scheduled appointment
to return to clinic; metropolitan Indianapolis; US.
RCT; Measurement: 2 yrs. Letter and phone reminder
67 KE Smith et al.
2004 [86]
Type 1 or 2 n = 16; ≥ 18 yrs old, no unstable cardiac disease
or organ transplantation, can read computer
monitor, and HbA1c > 8.5 %; Georgetown
University Hospital; US.
Non-randomized, prospective
feasibility; Measurements: baseline
and 6 mos.
Web-based
68 Song et al. 2009 [87] Type 2 nI.1 = 15, nC = 16; adults, new diagnosis type 2
diabetes, never attended formal self-
management education by health professional
or over internet; Seoul, Korea.
Quasi-experimental, non-equivalent
control group, pretest-posttest;
Measurements: baseline, 6 weeks, and
3 mos.
Web-based; Behavioral
69 Stone et al. 2012 [88] Not given nI.1 = 21, nI.2 = 23, nI.3 = 28, nI.4 = 29; age 18–79 yrs;
diagnosis defined as 12 or more months of
pharmacologic treatment for diabetes; HbA1c
≥ 7.5 %; no comorbid conditions indicating life
expectancy of less than 5 years; private
residence with telephone land line; VA
Healthcare System, Pittsburgh, Pennsylvania, US.
RCT; pretest-posttest;
Measurements: baseline, 3, and 6 mos.
Tele-monitoring (phone);
Performance feedback
Exclusion: Did not have a telephone landline.
70 Subramanian
et al. 2009 [23]
Type 2 nI = 3147, nC = 913; prescription refill for
hypoglycemic agent without polycystic ovarian
disease, HbA1c ≥ 9 % or elevated FBS
≥ 200 mg/dL; Indianapolis; US.
Retrospective, cohort; Measurements:
1 yr before intervention and 1 yr after.
Open access (OA)
Exclusion: missing all lab tests, vital signs, or visit
data in study period.
71 Tang et al. 2013 [89] Type 2 nI = 193, nC = 189; age ≥ 18 yrs; HbA1c ≥ 7.5 %;
seen within the past 12 months; a not-for-profit
healthcare organization in Palo Alto, California, US.
RCT; Measurements: Baseline,
6 and 12 mos.
Web-based; Performance
feedback; EHR; Behavioral
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Table 1 Summary of study designs and interventions (Continued)
Exclusion: initial diagnosis within the last
12 months; inability to speak or read English; lack
of regular internet access; unwillingness to
perform self-monitoring at home; diagnosis of a
terminal disease and/or entry into hospice care;
pregnancy, planning pregnancy or currently
lactating; enrollment in another care management
program; resident of a long-term facility; uninsured;
plans to discontinue primary care at current
location; family household member enrolled in
EMPOWER-D study.
72 Thomas et al.
2007 [26]
Not given nI = 78 resident physicians, nC = 39; Internal
Medicine residents; Mayo Clinic, Minnesota; US.
RCT; Randomization stratified by clinic day
across 5 practice sections; Measurements:
baseline and completion including prior
6 mos for HbA1c and prior 12 mos for lipids.
Registry; Evidence-based
guidelines; Performance
feedback; Letter reminder
73 Tildesley et al.
2010 [90]
Type 2 nI = 24, nC = 23; on insulin alone or with oral
hypo-glycemic medication, recent HbA1c
>7.0 %, internet access, and training in SMBG;
Vancouver, Canada
RCT; Measurements: baseline, 3 and 6 mos. Web-based; Performance
feedback
74 Weber et al. 2008 [53] Not given Gesinger Health System of 38 practice sites and
> 20,000 diabetes patients >18 years old in
40-county region of central and northeastern
Pennsylvania; US.
Retrospective, cohort; Measurements:
baseline time period (12 mos before) and
monthly after implementation of
intervention for 12 mos.
Registry; Evidence-based
guidelines; Provider
reminder; Performance
feedback
75 Yeh et al. 2006 [33] Type 2 nI = 134, nC = 140; medical teaching hospital in
Taipei, Taiwan
RCT; Measurements: pre-intervention and
post-intervention (8 month follow-up).
Web-based; SMS;
76 Yoo et al. 2009 [91] Type 2 nI = 57, nC = 54; age 30 and 70 yrs; hypertension
and type 2 diabetes diagnoses in last year; HbA1c
6.5–10.0 %; BP > 130⁄80 mmHg; BMI
≥ 23.0 kg⁄m2; Seoul, Korea.
RCT; Measurements: base line and 3 mos. Web-based; Phone
reminder; Telephone data
line; Automated
performance feedback;
SMS
Exclusion: Severe diabetic complications; liver
dysfunction with enzymes >2.5x normal, or renal
dysfunction, diagnoses of heart failure, angina,
myocardial infarction, or stroke, pregnancy or
lactation.
77 Yoon and HS Kim
2008 [92]
Type 2 nI = 25, nC = 26; ability to perform SBMG, access
websites, and cellular phone with web access;
university medical center, urban city of South
Korea.
RCT, pretest-posttest; Measurements:
baseline, 3, 6, 9, and 12 mos.
Web-based; SMS
Exclusion: severe illness, renal insufficiency with
creatinine > 1.5 mg/dL or on insulin pump.
I intervention group, C control group
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Table 2 Changes in HbA1c
Author On schedule To visit With information HbA1c at baseline Change in HbA1c P-value Comparisons tested
Intervention
group
Control group Intervention
group
Control group
39 Kirsh et al. 2007 [12] ✓ 10.4 9.8 −1.44 0.30 .002 Group × Time interaction @18 mo.
70 Subramanian et al. 2009 [23] ✓ 7.7 7.5 −0.19 −0.03 ≤0.05 Group × Time interaction @1 year
3 Avdal et al. 2011 [61] ✓ 8.0 8.1 −0.5 NA ≤.010 Time effect @6 mo.
NA 0.05 NS Time effect @6 mo.
5 Benhamou et al. 2007 [63] ✓ 8.3 8.2 −0.14 0.12 .097 Group effect @6 mo.
7 Bond et al. 2007 [36] ✓ 7.0 7.1 −0.6 −0.1 0.01 Group effect @6 mo.
8 Carter et al. 2011 [37] ✓ 9.0 8.8 −2.18 −0.9 ≤.050 Group effect @9 mo.
9 Cavan et al. 2003 [65] ✓ 9.7 NA −1.7a NA ≤.005 Patients with a disease duration≤ 10 years
Time effect @2 year
9.5 NA −0.3a NA NS Patients with a disease duration > 10 years
Time effect @2 year
12 Cho et al. 2009 [66] (phone) ✓ 8.3 NA −1.1 NA ≤.010 Time effect @3 mo.
Cho et al. 2009 [66] (internet) ✓ 7.6 NA −0.6 NA <.010 Time effect @3 mo.
13 Cho et al. 2011 [67] ✓ 8.0 8.0 −0.5 −0.2 <0.01 Time effect @3 mo.
18 Dijkstra et al. 2005 [54] ✓ 8.1 8.0 −0.3 0.2 ≤.001 Group effect @1 year
21 Farmer et al. 2005 [68] ✓ 9.2 9.3 −0.6a −0.4a 0.33 Group effect @9 mo.
24 Glasgow et al. 2003 [70]
(peer support)
✓ 7.54 7.35 −0.12 0.33 ≤.05 Group × Time interaction @10 mo.
Glasgow et al. 2003 [70]
(tailored self-management)
✓ 7.45 7.43 −0.03 0.24 NS Group × Time interaction @10 mo.
26 Grant et al. 2008 [55] ✓ 7.3 7.4 −0.16 −0.26 0.62 Group effect @1 year
27 Harno et al. 2006 [71] ✓ 7.82 8.21 −0.50 NA S p≤ .05 Group effect @1 year
NA −0.38 S
33 HS Kim et al. 2006 [42]
“Impact of a nurse short
message service intervention…”
✓ 8.1 NA −1.10 NA .006 Time effect @3 mo.
34 HS Kim 2007 [39]
“A randomized controlled trial
of a nurse short-message…”
✓ 8.09 7.59 −1.15 0.07 .005 Group × Time interaction @3 mo.
35 HS Kim 2007 [40]
“Impact of web-based nurse’s
education…”
✓ 6.92 6.71 −0.21 NA 0.20 Patients with a baseline HbA1c < 7 %
Time effect @3 mo.
NA 0.43 .034 Patients with a baseline HbA1c < 7 %
Time effect @3 mo.
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Table 2 Changes in HbA1c (Continued)
9.35 8.24 −2.15 NA ≤.007 Patients with a baseline HbA1c≥ 7 %
Time effect @3 mo.
NA 0.22 NS Patients with a baseline HbA1c≥ 7 %
Time effect @3 mo.
36 HS Kim and Jeong 2007 [41]
“A nurse short message service
by cellular phone…”
✓ 8.09 7.59 −1.05a 0.11a .008 Group × Time interaction @6 mo.
37 HS Kim and Song 2008 [43]
“Technological intervention for
obese patients with type 2
diabetes”
✓ 8.16 7.66 −1.09a 0a .043 Group × Time interaction @6 mo.
−1.09a NA ≤.050 Time effect @6 mo.
NA 0a NS Time effect @6 mo.
38 SI Kim and HS Kim 2008 [73]
“Effectiveness of mobile and
internet intervention…”
✓ 8.16 7.66 −1.49a 0.53a .017 Group × Time interaction @12 mo.
−1.49a NA ≤.050 Time effect @12 mo.
NA 0.53a NS Time effect @12mo.
39 Kwon et al. 2004 [74] ✓ 7.5 NA −0.5 NA ≤.003 Time effect @3 mo.
40 Kwon et al. 2004 [45] ✓ 7.59 7.19 −0.54 0.33 <0.05 Group effect @3 mo.
−0.54 NA ≤.050 Time effect @3 mo.
NA 0.33 NS Time effect @3 mo.
44 Lorig et al. 2010 [76]
(treatment, no reinforcement)
✓ 6.5 6.40 −0.03 0.13 0.04 Group effect @6 mo.
Lorig et al. 2010 [76]
(treatment and reinforcement)
✓ 6.43 0.02 0.13 0.16 Group effect @6 mo.
Lorig et al. 2010 [76]
(treatment combined)
✓ 6.47 −0.01 0.13 0.04 Group effect @6 mo.
46 McCarrier et al. 2006 [77] ✓ 7.99 8.05 −0.37 0.11 0.16 Group effect @12 mo.
49 McMahon et al. 2005 [78] ✓ 10.0 9.9 −1.6 −1.2 ≤.050 Group × Time interaction @12 mo.
50 McMahon et al. 2012 [47]
(online care)
✓ 9.6 NA −1.3 NA <.0001 Time effect @1 year
NS Group effect between online care and usual
care with web-training @1 year
McMahon et al. 2012 [47]
(telephone care)
✓ 9.9 NA −1.5 NA <.0001 Time effect @1 year
NS Group effect between telephone care and
usual care with web-training @1 year
McMahon et al. 2012 [47]
(usual care with web-training)
✓ 10.1 NA −1.7 NA <.0001 Time effect @1 year
52 Meigs et al. 2003 [49] ✓ 8.4 8.1 −0.23 0.14 0.09 Group × Time interaction @12 mo.
55 Moattari et al. 2013 [80] ✓ 9.1 9.4 −2.0 −0.6 <.001 Between group @3 mo.
56 Moorman et al. 2012 [81] ✓ 8.9 8.9 NA NA NS Between prospective (intervention) vs.
retrospective (control) group
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Table 2 Changes in HbA1c (Continued)
57 Musacchio et al. 2011 [82] ✓ 6.6 NA 0.2 NA NP Patients with a baseline HbA1c < 7.5 % @12 mo.
7.7 NA −0.4 NA NP Patients with a baseline HbA1c between 7.5 %
and 8 % @12 mo.
8.3 NA −0.9 NA NP Patients with a baseline HbA1c between 8 %
and 9 % @12 mo.
10.0 NA −2.2 NA NP Patients with a baseline HbA1c > 9 % @12 mo.
58 Nes et al. 2012 [83] ✓ 7.4 NA −0.4 NA NP @3 mo.
61 Ralston et al. 2009 [38] ✓ 8.2 7.9 −0.9 0.2 0.01 Group × Time interaction @12 mo.
62 Ryan et al. 2013 [85] ✓ 7.5 NA −0.6 NA 0.04 Time effect @ 13 mo.
63 Sacco et al. 2009 [48] ✓ 8.4 8.5 −1.0 −0.7 NS Group effect @6 mo.
67 KE Smith et al. 2004 [86] ✓ 10.95 NA −2.22 NA 0.001 Time effect @6 mo.
68 Song et al. 2009 [87] ✓ 7.6 7.7 −0.8a −0.4a 0.26 Group × Time interaction @3 mo.
69 Stone et al. 2012 [88]
(Active care management to
care coordination with home
telemonitoring)
✓ 7.77 NA 0.26 NA NS Time effect @ 6 mo.
Stone et al. 2012 [88]
(Active care management to
care coordination)
✓ 7.97 NA 0.19 NA NS Time effect @ 6 mo.
Stone et al. 2012 [88]
(Care coordination to care
coordination)
✓ 8.56 NA 0.15 NA NS Time effect @ 6 mo.
Stone et al. 2012 [88]
(Care coordination to usual care)
✓ 8.53 NA 0.31 NA NS Time effect @ 6 mo.
71 Tang et al. 2013 [89] ✓ 9.2 9.3 −1.1 −1.0 0.13 Between group @1 year
73 Tildesley et al. 2010 [90] ✓ 8.8 8.5 −1.2a −0.1a ≤.050 Group effect @6 mo.
−1.2a NA ≤.001 Time effect @6 mo.
NA −0.1a 0.51 Time effect @6 mo.
76 Yoo et al. 2009 [91] ✓ 7.6 7.4 −0.5 0.2 ≤.001 Group × Time interaction @3 mo.
77 Yoon and HS Kim 2008 [92] ✓ 8.09 7.59 −1.32a 0.81a ≤.001 Group × Time interaction @12 mo.
65 Seto et al. 2012 [16] ✓ ✓ 7.3 NA −0.3 NA <.001 Time effect @ 8 mo.
4 Bailie et al. 2004 [62] ✓ ✓ 9.0 NA −0.2a NA 0.23 Time effect @3 years
11 Cho et al. 2006 [57] ✓ ✓ 7.7 7.5 −1.0a −0.1a ≤.050 Group effect @30 mo.
16 de Grauw et al. 2002 [19] ✓ ✓ 8.2 NA −1.1 NA ≤.001 Unpaired t-test @6 year
30 Jones and Curry 2006 [50] ✓ ✓ 7.25 7.13 0.06 −0.18 0.24 Group effect within 16 months
45 MacLean et al. 2009 [20] ✓ ✓ 7.11 7.03 0.05 −0.02 0.08 Group × Time interaction @32 months
64 Sadur et al. 1999 [22] ✓ ✓ 9.7 9.6 −1.3 −0.22 ≤.0001 Group effect @6 mo. or beyond
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Table 2 Changes in HbA1c (Continued)
28 Holbrook et al. 2009 [28] ✓ ✓ 7.0 7.1 −0.2 0.2 0.03 Group effect @6 mo.
29 Hurwitz et al. 1993 [72] ✓ ✓ 10.4 10.3 −0.4 0.3 NP Group effect @2 year
48 McDiarmid et al. 2001 [51] ✓ ✓ 8.0 NA −0.1 NA NP Time effect @1 year
53 Meulepas et al. 2007 [30] ✓ ✓ 7.2 7.4 0 0.6 ≤ .050 Group effect @2 year after intervention (baseline
1 year before intervention)
54 Meulepas et al. 2008 [31] ✓ ✓ 7.3 7.2 −0.2 0.1 <0.05 Group × Time interaction @3 years
72 Thomas et al. 2007 [26] ✓ ✓ 7.3 7.4 −0.02 −0.01 0.83 Group × Time interaction @ 1 year
75 Yeh et al. 2006 [33] ✓ ✓ 9.03 8.95 −1.65 −0.92 0.01 Group effect @8 mo.
42 Lin et al. 2007 [29] ✓ ✓ ✓ 7.8 7.7 −0.6 NA ≤.050 Time effect @3 year
NA −0.3 0.24 Time effect @3 year
NS Non-significant (p-value>0.05), S Significant (p-value≤0.05), NA Not applicable, NP Not provided
Results are differences in mean before and after implementation of intervention except those indicated with the following superscripts
aMultiple measurements are presented over time after the intervention in the paper, but the last measurement is used to calculate the difference in this table
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or 12 months after the intervention [14]. In another RCT,
patients receiving a phone reminder to schedule an appoint-
ment 10 days following a letter reminder had significantly
higher return rates for an annual follow-up eye exam than
those patients who received only a reminder letter [15]. In a
pretest/posttest study, phone calls made by medical assis-
tants to schedule follow-up appointments with the primary
care provider significantly improved glycemic control (re-
duced HbA1c levels) for the patients who returned for their
follow-up visit [16]. In another study using RCT, phone calls
to schedule an appointment with a pharmacist approxi-
mately one week prior to the physician appointment signifi-
cantly improved compliance to ADA standards of care
including percentage of patients who had A1c test, fasting
lipid profile, foot exam and vaccinations [17]. An automated
outreach call to non-adherent patients advising them to
schedule an appointment significantly improved the per-
centage of patients with a provider visit and with HbA1c
test for those patients who were successfully reached [18].
In a multi-center cross-sectional study, a phone call to
reschedule after a no-showed appointment for a periodic
provider visit resulted in significantly increased patient at-
tendance to annual provider review, and those patients who
attended their annual review had significantly lower fasting
blood glucose [19].
Different than the studies that consider reminders to pa-
tients only, one study combined reminders to the patient
with reminders to the provider [20]. In a RCT, faxed re-
minders were sent to the provider for patient overdue la-
boratory tests and letter reminders were sent to the patients
with a warning of overdue laboratory tests. Even though the
decrease in HbA1c and LDL of the intervention group when
compared to control group was not significant, the number
of emergency visits and number of hospital days per year
were reduced significantly [20].
Comprehensive diabetes management programs that are
used to monitor patient status can also be used to facilitate
scheduling of patients for their provider visits. In a retro-
spective cohort study, the care coordinator regularly
reviewed patient uploaded information such as SMBGs and
Table 3 Summary of outcomes and statistically significant results relating to getting patients on the schedule
Type of intervention Primary outcomes Studies analyzing primary outcomes Studies with significant results References
Phone Reminder ↓HbA1c 3 3 [16, 19, 29]*
↓SBP 2 0 [19, 29]
↓Cholesterol 2 2 [19, 29]*
↑# HbA1c tests 4 4 [16–19]*
↑# of provider visits 2 2 [18, 19]*
↑Eye exam 2 2 [15, 17]*
Letter/Mail Reminder ↓HbA1c 3 1 [20, 50] [12]*
↓SBP 2 1 [50] [12]*
↓Cholesterol 3 0 [12, 20, 50]
↑# HbA1c tests 3 1 [13, 20] [14]*
↑# of provider visits 2 1 [14] [20]↓*
↓ED visit rate 1 1 [20]*
↓Hospitalization rate 1 1 [20]*
↑Eye exam 3 3 [14, 15, 50]*
Scheduling when necessary
while monitoring patient
↓HbA1c 1 1 [22]*
↑# of provider visits 2 1 [22] [21]*
↓ED visit rate 1 1 [21]*
↓Hospitalization rate 2 2 [21, 22]*
↑Eye exam 1 0 [21]
Open access scheduling ↓HbA1c 1 1 [23]*
↓Cholesterol 1 0 [23]
↑# HbA1c tests 1 0 [23]↓*
↑# of provider visits 1 0 [23]
↓ED visit rate 1 0 [23]
↓Hospitalization rate 1 0 [23]
*indicates significant findings with p-value ≤0.05; ↓=decrease, ↑increase
NP p-value is not given
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scheduled provider appointments when appropriate, result-
ing in significantly decreased percentage of patients with at
least one emergency visit and hospital admission [21]. In an-
other RCT, a nurse reviewed self-management by phone at
regular intervals, and a multidisciplinary care team provided
both group visits every month for 6 months and individual
visits after patient self-referral or referral by another care team
member. The HbA1c levels and number of hospital admis-
sions significantly reduced for the intervention group [22].
Open access, a scheduling strategy that offers same-day
appointments for patients, can aide patients in scheduling a
provider appointment and needed laboratory testing [23]. A
drawback with this type of scheduling strategy is that the pa-
tient has the responsibility to initiate the next appointment
at the appropriate time as specified in diabetes practice
guidelines. If the patient forgets the timing of laboratory
tests and provider visits, and the clinic does not send re-
minders to the patient for scheduling their appointments,
open access scheduling might reduce compliance to diabetes
management guidelines. One retrospective cohort study
showed that open access scheduling was associated with sig-
nificant decrease in HbA1c and urine microalbumin testing
[23]. Even though HbA1c levels, and the number ED visits
and hospitalizations did not change significantly with open
access scheduling, the study suggested that scheduling
process should be adjusted for patients with diabetes to
improve diabetes processes of care (HbA1c, LDL, urine
microalbumin testing) [23].
To the visit
Attendance to provider appointments and laboratory testing
is a necessary component for implementation of diabetes
preventive care. Interventions facilitating patient attendance
to the scheduled provider appointments or laboratory testing
meet criteria for the focus area ‘to the visit’. Review of the lit-
erature found fewer studies discussing interventions to facili-
tate getting the patients to their provider visits as compared
to diabetes intervention research pertaining to communica-
tion of patient information to the provider. The interven-
tions that are used to improve attendance to the scheduled
visits include letter, phone call, and SMS reminders, and fi-
nancial incentives, as summarized in Table 4. Phone and
mail reminders were the interventions most studied to
facilitate patient appointment attendance with positive clin-
ical outcomes. More studies are needed to determine if
SMS and web-based appointment reminders and financial
incentives can also improve provider visit attendance.
Our literature review showed that letter reminders to pa-
tients regarding lab appointment information were associ-
ated with significantly increased average number of HbA1c
tests within the study period, number of patients who had
HbA1c test within 6 months, and percentage of patients
Table 4 Summary of outcomes and statistically significant results relating to getting patients to the visit
Type of intervention Primary outcomes Studies analyzing primary outcomes Studies with significant results References
Phone Reminder ↓HbA1c 5 5 [16, 28–31]*
↓SBP 4 2 [29, 31] [28, 30]*
↓Cholesterol 4 1 [28, 30, 31] [29]*
↑# HbA1c tests 5 4 [32] [16, 25, 28, 30]*
↑# of provider visits 2 2 [27, 28]*
↓Hospitalization rate 2 1 [27] [32]*
↑Eye exam 2 2 [30, 32]*
↑Foot exam 3 3 [28, 30, 32]*
Letter Reminder ↓HbA1c 2 0 [26] [72]NP
↓SBP 1 0 [26]
↑# HbA1c tests 3 3 [24–26]*
↑# of provider visits 1 1 [27]*
↓Hospitalization rate 1 0 [27]
SMS Reminder ↓HbA1c 1 1 [33]*
↓Cholesterol 1 1 [33]*
Financial incentive ↓SBP 1 1 [34]*
↑# HbA1c tests 1 1 [24]*
↑# of provider visits 1 0 [34]↓*
↓ED visit rate 1 1 [34]*
↓Hospitalization rate 1 0 [34]
*indicates significant findings with p-value≤0.05; ↓=decrease, ↑increase
NP p-value is not given
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Table 5 Summary of outcomes and statistically significant results relating to collecting patient information
Type of intervention Primary outcomes Studies analyzing
primary outcomes
Studies with
significant results
References
Web-based management
with feedback
↓HbA1c 33 26 [68, 70, 77, 87, 89] [36–43, 45, 47, 57, 61, 65–67, 71,
73, 74, 76, 78, 80, 85, 86, 90–92]* [72, 83]NP
↓SBP 10 3 [37, 38, 47, 85, 86, 89] [36, 78, 91]* [71]NP
↓Cholesterol 20 8 [38, 44, 45, 47, 57, 66, 74, 78, 85, 86, 92] [36, 43, 67,
70, 80, 89–91]* [71]NP
↑# of provider visits 3 1 [76, 89] [61]*
↑QOL 2 0 [85] [83]NP
↑Self-efficacy 2 1 [76] [77]*
Phone/SMS/Mail ↓HbA1c 6 1 [48, 63, 81, 88] [47]* [82]NP
↓SBP 1 1 [47]*
↓Cholesterol 2 1 [47] [88]*
↑# of provider
visits
2 1 [21] [46]↓*
↑Eye exam 1 1 [58]*
↑Foot exam 1 1 [58]*
↓ED visit rate 2 1 [46] [21]*
↓Hospitalization rate 2 1 [46] [21]*
↑QOL 4 2 [58, 84] [46, 63]*
↑Self-efficacy 2 2 [48, 84]*
↑SMBG testing 4 2 [63, 81] [58, 69]*
Decision support;
Evidence based guidelines
↓HbA1c 7 2 [29, 49, 50, 62] [28, 33]* [51]NP
↓SBP 5 2 [29, 50, 62] [28, 49]*
↓Cholesterol 5 2 [28, 49, 50] [29, 33]*
↑# HbA1c tests 5 5 [17, 28, 49, 51, 62]*
↑# of provider
visits
1 1 [28]*
↑Eye exam 5 4 [49] [17, 50, 51, 62]*
↑Foot exam 6 6 [28, 49–51, 62, 75]*
Registry ↓HbA1c 3 1 [20, 26] [19]*
↓SBP 2 0 [19, 26]
↓Cholesterol 3 1 [20, 26] [19]*
↑# HbA1c tests 6 3 [13, 20, 52] [19, 26, 53]*
↑# of provider visits 2 1 [19] [20]↓*
↓ED visit rate 1 1 [20]*
↓Hospitalization rate 1 1 [20]*
↑Eye exam 1 1 [52]*
↑Foot exam 1 1 [52]*
↑QOL 1 0 [20]
Personal health records ↓HbA1c 2 1 [55] [54]*
↓SBP 1 0 [54]
↓Cholesterol 2 0 [54, 55]
↑# HbA1c tests 1 0 [54]
↑Eye exam 1 0 [54]
↑Foot exam 1 1 [54]*
*indicates significant findings with p-value≤0.05; ↓=decrease, ↑increase
NP p-value is not given
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who completed the HbA1c test within a certain period after
the reminder [24–26]. In a RCT, letters recommending ap-
propriate laboratory testing were automatically mailed quar-
terly to patients without HbA1c tests in the last six months or
without LDL within the last twelve months resulting in signifi-
cantly increased number of patients who had HbA1c test
within 6 months and LDL test within 12 months [26]. Letter
reminders one week before the scheduled provider appoint-
ment significantly increased the number of provider visits and
reduced the number of hospitalizations in another RCT [27].
Phone reminders to patients regarding provider visits and
laboratory testing resulted in improved HbA1c levels [16,
28–31]. One study showed that monthly phone reminders
to patients in the intervention group regarding laboratory
or provider scheduled appointments resulted in signifi-
cantly decreased HbA1c levels and systolic blood pressure
in the intervention group when compared to the control
group [28]. Two studies where the medical assistant or the
secretary called each patient before their scheduled ap-
pointment day to remind them of the appointment were
associated with significantly decreased HbA1c [16, 29] and
LDL levels [29]. In two studies using a controlled, non-
randomized before/after design, a Diabetes Support Service
(DSS) called patients in the intervention group to remind
them of scheduled appointments for laboratory testing, foot
exam, fundus photography and scheduled appointments
with the dietician and diabetes nurse. The intervention was
associated with a significantly increased percentage of pa-
tients with at least four HbA1c tests a year [30] and signifi-
cantly lower HbA1c levels in the intervention group when
compared to the control group [30, 31].
Letter reminders combined with phone reminders of
the date and time of the patient’s provider appoint-
ment or laboratory test resulted in improved health
outcomes [25, 27, 32]. One study showed that a recall
card system and phone call reminding patients of their
scheduled follow-up appointment resulted in significantly
increased the percentage of patients who had HbA1c
within the last 6 months and LDL tests within the last
12 months, significantly decreased the percentage of pa-
tients hospitalized in the last 12 months, and significantly
increased the percentage of patients with foot exams and
eye exams in the last 12 months [32].
Web-based programs associated with self-management
can successfully remind patients regarding provider appoint-
ments or laboratory testing. A RCT used a web-based system
to improve self-management education, and used emails
combined with short message service (SMS) to send re-
minders one week before the follow-up visit, and to remind
the time of the HbA1c test if it is more than three months
overdue [33]. This web-based education management system
combined with email and SMS reminders resulted in signifi-
cantly decreased HbA1c and total cholesterol levels in the
intervention group compared to control group [33].
Financial incentives used with other interventions have the
potential to improve attendance to scheduled visits or
needed lab tests. In a quasi-experimental study, a reminder
letter was sent to patients for the completion of lab tests,
and were offered and provided a gas card when the tests
were completed [24]. The study showed that the reminder
letter combined with a financial incentive increased the
number of HbA1c tests significantly [24]. In another study,
structured group visits facilitated by a diabetes educator were
used as the main intervention [34]. A $10-incentive was pro-
vided to the patients for each group visit they attended [34].
Group visits combined with financial incentive achieved an
overall attendance of 78.4 % to group visits, and significantly
reduced SBP levels and number of ED visits per year [34].
Patient information
ADA, Healthy People 2020 and the Chronic Care Model
recognize the primary importance and responsibility of the
patient in self-managing their diabetes care and collaborat-
ing with their providers to set treatment and goals for im-
proved health outcomes [4, 5, 35]. Interventions that aide
the patient in communicating important information re-
garding SMBGs, daily diet and nutrition, exercise or physical
activity, medication information and compliance, and pa-
tients’ needs to their provider or health care team meet con-
ditions for the focus area ‘with patient information’ (see
summary of interventions and findings in Table 5). This
focus area of the literature review provided the greatest
number of research studies when compared to the other
two focus areas, ‘on the schedule’ or ‘to the visit’. Systems
with routine monitoring of patient information, managing
patient medications and supporting patients’ goals whether
web-based, SMS, or Electronic Health Record (EHR) with
interfaced registry, consistently showed improved patient
clinical outcomes.
This literature review identified multiple studies using
web-based diabetes management interventions with care
manager feedback. In a RCT study, patients entered SMBG
readings, exercise amounts, weight changes, blood pressure,
and medication data via a web portal [36]. The study nurse
monitored self-management changes, and contacted pa-
tients using email or chat to make recommendations [36].
The intervention resulted in significantly decreased HbA1c,
systolic blood pressure and total cholesterol levels in the
intervention group as compared to the control group who
visited their provider for usual care [36]. In another RCT
study, a nurse contacted patients biweekly for a 30 min
video conference to review biometric data uploaded to the
web-based self-management module and discuss patients’
problems in managing the disease [37]. The intervention
significantly decreased HbA1c levels in the intervention
group [37]. Another study, which used randomized, single-
centered, controlled trial with parallel group design, evalu-
ated a web-based program used by patients to review their
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online medical records, upload their SMBG levels, enter in-
formation about their exercise, diet and medication, and
send secure emails to the care manager [38]. The care man-
ager reviewed SMBG readings, guided health behavior, ad-
justed medications, and responded to patients’ messages
[38]. This web-based program, which provided ongoing
tracking and documentation of patients’ needs and care, de-
creased HbA1c levels significantly [38]. Seven studies com-
bined web-based diabetes management program with SMS
and were associated with significantly decreased HbA1c
levels for the intervention group after implementation [39–
45]. In six of those studies using quasi-experimental pretest/
posttest method conducted by the same research group, the
nurse researcher reviewed uploaded patient data on the
website, integrated patient clinical information into the pa-
tients’ EHRs, provided education for self-management and
sent weekly medication adjustment advice to the patient via
SMS and internet [39–44].
Two studies showed that patients using a telephone
data line to answer care coordinator’s questions regard-
ing daily SMBG readings, medication compliance and
symptoms which were forwarded to the provider were
associated with significantly increased quality of life
(QOL) [46] and significantly decreased the percentage of
patients with emergency visits and hospital admissions
[21]. One study showed that patients receiving bi-weekly
phone calls to review glucose and blood pressure read-
ings had significantly reduced HbA1c and SBP levels
[47]. Another study showed weekly phone coaching for
goal setting and self-management significantly improved
self-efficacy, diet, exercise, and foot care [48].
This literature review showed that the tools enabling
decision support at the time of patient contact could
improve compliance with preventive care services. A disease
management application, which displayed trended electronic
laboratory data linked to evidence-based treatment recom-
mendations, resulted in significantly increased average num-
ber of HbA1c and LDL tests per year in a RCT study [49].
Patient data entered into Personal Digital Assistant (PDA),
which enabled the tracking of evidence-based guidelines and
provided reminders of due or overdue tests to providers at
each patient visit, improved compliance to eye and foot
exams [50]. The Diabetes Questionnaire and Reminder
sheet, which is completed by the patient at check-in and
reminded providers to check feet and update diabetes care
flow chart used to document dates of preventive services in
patient’s chart, increased the number of HbAc1 tests, and
compliance to eye and foot exams [51].
The utilization of an EHR driven diabetes registry within
an integrated delivery system can improve diabetes health
outcomes. A multicenter cross-sectional study showed that
a computerized registration with templates for recording pa-
tient data from quarterly or annual diabetes visits integrated
with patient’s EHR resulted in significantly increased
percentage of patients with HbA1c tests, and significantly
decreased HbA1c, total cholesterol and triglycerides levels
[19]. In a RCT study, a laboratory-based registry was used to
fax and/or mail laboratory results, reminders of overdue la-
boratory tests, and quarterly population reports to providers,
and to mail reminders for overdue tests and alerts for ele-
vated test results to patients [20]. The integration of registry
with patient and provider decision support decreased acute
care utilization significantly, but did not decrease HbA1c
level significantly [20]. A diabetes registry can be used to
generate provider performance audits or provider patient
panel reports to provide feedback regarding achievement of
diabetes care guidelines including HbAc < 7.0 %. In three
studies, these reports were shown to be associated with sig-
nificantly improved diabetes processes of care (percentage of
patients who had HbA1c test in the last six months, annual
LDL cholesterol test, annual dilated eye exam, annual foot
exam, and annual influenza vaccine) [26, 52, 53].
Personal patient held records summarizing goals, medical
and laboratory outcomes for the year can assist both pa-
tients and providers as they organize individualized diabetes
treatment plans. One study using clustered RCT showed
that the intervention group utilizing patient-held health re-
cords resulted in significantly decreased HbA1c levels in the
intervention group as compared to the control group [54].
However, web-based personal health records that allowed
patients to review their medication lists, most recent test re-
sults and current treatments before the visit did not im-
prove HbA1c levels in another RCT study [55].
Discussion
ADA and Healthy People 2020 recommended diabetic pa-
tients have routine laboratory tests and provider visits at
regular intervals [4, 5]. This literature review evaluated dia-
betes interventions, their effectiveness and resultant health
outcomes, focusing upon the areas of scheduling the patient,
getting the patient to their provider visit, and having patient
information available to the provider. Figure 2 summarizes
our findings by illustrating patient flow through the complex
medical outpatient care delivery process with all potential
interventions identified in this review. More specifically,
Fig. 2 shows various components of diabetes outpatient care
delivery, identifies phases of the process when interventions
could be applied, identifies potential types of multifaceted
interventions that could be utilized, and distinguishes whose
responsibility it is for successful navigation through each
phase of the care delivery system, e.g., provider and health
care team versus patient.
Identifying gaps and highlighting future research
opportunities
Diabetes management requires continuous monitoring and
routine provider visits and laboratory tests [4]. This litera-
ture review showed that routine visits are either scheduled
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in advance or reminders are sent to patients to schedule
their next appointment. When appointments are scheduled
in advance, the attendance to scheduled visits might de-
crease as the lead time between the time the appointment is
scheduled and the actual appointment time increases [56].
Therefore, advanced scheduling should be integrated with
other interventions used to improve attendance to sched-
uled visits. In addition, clinics are moving from advanced
scheduling to open access scheduling to reduce waiting
times and improve access to care. However, one study
showed that open access scheduling negatively affected the
process outcomes for diabetes patients [23]. The mixed find-
ings demonstrate the importance of provider or care team
initiated interventions such as reminders sent to patients to
schedule an appointment, or monitoring of patient informa-
tion and scheduling when needed. The literature review
showed that implementing automated or personalized
phone reminders, which are relatively simple interventions
and easy to employ by provider practices, are very useful in
improving appointment making and attendance behavior.
Web-based diabetes management tools are used to con-
tinuously monitor patient information and provide feedback
to the patient. The continuously monitored patient informa-
tion might include SMBG readings, patient medication use,
blood pressure, weight, and nutrition or daily calorie intake.
The degree of interaction with patients might range from
providing feedback about SMBG readings by care manager
to online coaching and structured counseling by diabetes
specialist or nurse practitioner. The web-based systems can
also be used to integrate laboratory testing and clinical infor-
mation into patient’s EHR. Web-based tools require patient,
provider and care team involvement. Although a few of the
studies discussed ease of use of the web-based interventions
by patients and review patient satisfaction [46, 57, 58], none
of the studies in this literature review discussed the ease of
use for providers, provider satisfaction, or impact to the pro-
vider workload. Most of the web-based interventions using
care manager monitoring and feedback used small sample
sizes and did not discuss the direct and indirect costs and ease
of implementation of the interventions for larger populations.
More studies discussing provider workload and information re-
garding costs of the intervention may aid a practice in deter-
mining which inventions are most suited for their practice.
Selective financial incentives can improve quality of health
services [59]. Three of the studies in this literature review in-
corporated financial incentives within the intervention. In
one study, a gas card was given to patients after the comple-
tion of laboratory tests (HbA1c and LDL) and was associ-
ated with significantly increased laboratory testing when
combined with a written reminder [24]. Another study dis-
cussed monetary incentives to providers for improving dia-
betes processes of care as demonstrated by significant
increases in the percentage of patients with ideal glucose
levels (HbA1c < 7.0 %) when combined with provider
feedback and computerized reminders [53]. More research
is necessary to determine the effect of both patient and pro-
vider financial incentives on patient health outcomes.
Tailoring the interventions according to patient popula-
tion characteristics, needs, capabilities, and skills is an im-
portant factor that should be considered while choosing the
set of interventions for implementation. For example, a
web-based self-management program may not be as appro-
priate for elderly patients who may not be as comfortable
with computer usage as a younger patient. The patients who
have cellphones may not answer phone calls, but respond to
SMSs. With the increasing use of smartphones, the patients
might have regular access to email. However, underserved
populations may not even have a regular phone or minutes
to answer phone calls/SMSs in their cellphones. Changing
technology and patient preferences with regard to contact/
communication should be considered when determining the
future interventions to improve usage and effectiveness. Re-
search evaluating the usage of interventions tailored for dif-
ferent patient groups is needed. Web-based tools with
continuous monitoring can be used to categorize patients
according to risk groups. Structured counseling and pro-
active scheduling of provider appointments might be used
for high-risk patients to reduce the acute care utilization.
This literature review identified several interventions that
improve appointment management and preparation. While
impact of interventions on several clinical and behavioral
outcomes is evaluated in these studies, effectiveness of inter-
ventions is not evaluated from a systems perspective. In
other words, the interventions in the literature we reviewed
appeared to be examined in isolation when they may, in fact,
have repercussions throughout a provider’s practice and pa-
tient population. Other factors such as ease of use by pa-
tients and providers, applicability of the intervention for
larger populations and across other chronic diseases, and
the cost of implementation are important concerns that
may influence providers’ decisions about adopting interven-
tions in their practices. Research is needed that includes a
more systematic view of the interventions and their implica-
tions beyond patient outcomes.
The methodologies used in the reviewed papers vary
widely (including RCTs, quasi-experimental, pretest-posttest,
retrospective cohort, non-randomized controlled trial,
nested randomized trial, etc.). Even though RCT is consid-
ered as the best method in terms of strength and validity of
the results, the reviewed studies that use other methods usu-
ally consider an intervention that can easily be implemented
in large patient populations. These interventions include
phone, letter/mail and SMS reminders to schedule an ap-
pointment or remind a scheduled appointment, and dia-
betes registries, and decision support systems to improve
compliance to diabetes management guidelines. Since these
interventions use large sample sizes, the included studies
prove the applicability and impact of these interventions.
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For the studies that consider using a web-based system with
care coordinator feedback, RCTs are used with smaller sam-
ple sizes. Even though RCTs show the positive impact of
such kind of an intervention, the small sample size might be
an indicator of the difficulty of implementation due to the
cost of the intervention.
Limitations
While the search in this literature review was conducted
using several key databases and references were cross-
checked, there may be publications not incorporated in
the review because of the MESH terms used and inclusion
criteria utilized. Only studies published in English were
included which may create a chance for potential bias. All
studies included in the literature review were peer-
reviewed publications. Although some interventions may
be dated due to inclusion of studies published as early as
1987, less sophisticated interventions may have the same
or better payoff and achieve similar goals at less cost and
complexity in implementation.
One limitation of this literature review is that a meta-
analysis was not performed due to inconsistency of the re-
ported outcomes [60]. The included studies report a wide
range of outcomes. Especially, the behavioral outcomes in
Appendix 3, are not consistent. The measures related to
self-management use different survey tools to assess pa-
tient satisfaction, quality of life, self-efficacy, etc. Other
measures such as lab tests completed, vaccinations, pro-
vider visits, hospitalizations, and ED visits, are reported as
either percentages or numbers (i.e. “percentage of patients
who had ED visits” vs. “number of ED visits”). For clinical
outcomes, the studies might report time effect, group ef-
fect, or time × group effect, which is again not consistent
from study to study. Some studies did not use a control
group or did not provide enough information before or
after the intervention. This inconsistent reporting of wide
variety of outcomes, and limited number of studies repre-
senting each outcome made the meta-analysis impractical.
Conclusions
The literature review showed that interventions from the
simplest phone and letter reminder for scheduling or
prompting of the date and time of an appointment to more
complex web-based multidisciplinary programs with patient
self-management can have a positive impact on clinical and
behavioral outcomes for diabetes patients. Multifaceted in-
terventions aimed at appointment management and prepar-
ation during various phases of the medical outpatient care
process may provide a fail-safe against diabetes patients fall-
ing through the cracks of a fissured health care delivery sys-
tem and maximize patient-provider limited time while
obtaining the best possible disease management. While the
overall results from this review suggest that interventions as-
sociated with appointment management and preparation
result in better patient outcomes, an overwhelming absence
of financial information in the reviewed studies may inhibit
implementation. Indeed, practices may see an increase in
costs associated with dedicated care managers and informa-
tion technology support. Patients, and their insurers, may
see an overall decrease in the costs of care when proper dis-
ease management is practiced. Unfortunately, these cost off-
sets may not be within the same cost center, and therefore,
the providers paying for the interventions may not realize
the cost benefits of enhanced patient well being. Future re-
search must address these cost concerns and new policies
may be necessary to ensure that interventions are beneficial
for patients and providers.
This literature review also revealed that the trend of dia-
betes care is moving toward frequent monitoring of patient
data and fluid management of patient diabetes care. Com-
plex web-based systems are being overseen by an intermedi-
ate care manager, which may be an advance practice nurse,
physician assistant or diabetes educator for 1) monitoring of
SMBG levels, laboratory tests, medication compliance, diet
and nutrition, physical activity and, 2) directing changes in
patient care based on patient information. This intermediate
care manager also directs the flow of patient information to
provider, specialist and other members of the multidisciplin-
ary health care team. The questions are whether the future
of diabetes care and this type of continual monitoring will
concentrate provider visits more toward those patients
whose diabetes are not well-controlled or have a higher se-
verity and what impact this change will have on overall dia-
betes outcomes. It seems reasonable that with the predicted
increases in diabetes incidence and the already overloaded
provider schedules that new strategies are needed to ensure
access to care for all diabetes patients. Such strategies must
include technical innovation that moves beyond the clinic
visit, including continuous monitoring and risk assessment
using emerging sensor technologies and smart algorithms,
(semi) automated selection, execution, and tracking of in-
terventions, learning algorithms to customize patient care
plans, and gamification strategies to motivate and engage
patient behaviors. Further, comprehensive cost-benefit ana-
lysis must become more widely accepted and practiced.
The short and long term costs of interventions (capital,
operational, maintenance, cyberinfrastructure, etc.) must be
balanced against expected benefits from all stakeholder per-
spectives including patient access, outcomes, and satisfac-
tion, clinic performance and provider utilization, inpatient
usage patterns, reimbursement policies, and overall sustain-
ability of the healthcare system. These strategies must be
part of the larger, on-going efforts to transform healthcare
delivery from being an uncoordinated assortment of spe-
cialties and special interests, supported by fee for service,
to an integrated and holistic system that provides value to
patients through prevention, early diagnosis, avoidance of
chronic complications, and excellent therapy.
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Table 6 Detailed information about interventions
Author Intervention description Other information
1 Anderson et al. 2003 [15] On the schedule: Standard (control) and intensive personalized
(intervention) groups received reminder letter with date, time,
location of eye clinic, toll-free number one month before annual
exam to schedule an appointment.
IP follow-up group: phone discussion about diabetic eye
disease and transportation arrangement to exam.
Intensive personalized (IP) group received phone call if appointment
not scheduled within 10 days of reminder letter date.
To the visit: Not applicable (NA)
Patient information: NA
2 Austin and Wolfe 2011 [24] On the schedule: NA NA
To the visit: Pilot group received reminder letter signed by physician
to go to the clinic to have HbA1c or LDL-C tests and are offered a
gas card if they receive the tests.
Patient information: NA
3 Avdal et al. 2011 [61] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group entered self-measured blood
glucose (SMBG) tests, accessed education, and could send messages
to researcher through web site. SMBG graphics and profile were
available to patient via web site.
4 Bailie et al. 2004 [62] On the schedule: Scheduling guideline services integrated with
computerized information system identifying patients due for
scheduled services.
NA
To the visit: NA
Patient information: Audit of guideline adherence per participant,
e.g., target blood pressure 130/80 mm Hg, percentage with
HbA1c <7 %. Reminder to providers when patients’ scheduling
services due.
5 Benhamou et al. 2007 [63] On the schedule: NA NA
To the visit: NA
Patient information: Patients downloaded SMBG levels to SMS weekly
and received medical feedback. Data transmitted to software module
creating and managing patient files on database.
6 Bond et al. 2006 [64] On the schedule: NA NA
To the visit: NA
Patient information: Participants accessed website to: access library,
receive on-line counseling, receive tailor self-management
instruction, participate in weekly problem-solving discussion with
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Table 6 Detailed information about interventions (Continued)
nurse, use bulletin board to post goals, and enter SMBG, medication,
diet, weight and BP.
7 Bond et al. 2007 [36] On the schedule: NA Intervention group: weekly online education discussion;
Control group: access to educational materials via
classroom or internet.To the visit: NA
Patient information: Online (asynchronous [email and bulletin board]
and synchronous [instant messaging and chat]) with study nurse.
Participant entered SMBGs, exercise, weight, blood pressure, and
medication via web portal. Study nurse accessed participants’ logs
monitoring self-management patterns. Study nurse contacted
participant via email or chat.
8 Carter et al. 2011 [37] On the schedule: NA Intervention group: Access to health education module
with culturally age-appropriate education through videos
and web sites, and social networking module linking
intervention participants.
To the visit: NA
Patient information: Self-management module: Nurse contacted
patients biweekly for 30 minutes by video conference and reviewed
uploaded data while patient viewed self-management video. Nurse
and patient discuss data and behavior-change strategies. Patients
would discuss problems in managing disease, e.g., medication side
effects, and nurse provided feedback. Nurse transmitted data to
patient’s EHR (electronic health record). Provider transmitted updated
treatment plans, lab results and other orders via portal to nurse and
patient.
9 Cavan et al. 2003 [65] On the schedule: NA NA
To the visit: NA
Patient information: Patients used DiasNet computer model to
display and analyze SMBG levels, and problem solve via internet.
Data was analyzed and discussed in weekly group sessions.
10 Cherry et al. 2002 [46] On the schedule: NA Patients received free blood glucose monitoring equipment.
To the visit: NA
Patient information: Patients answered daily questions (changes in
feet, blood sugar and medication) with Health Buddy (phone tool).
Care manager using browser-based tool could automatically risk
stratify information, forward patient information to provider, make
provider referrals and reinforce self-management.
11 Cho et al. 2006 [57] On the schedule: Intervention and control patients scheduled for
outpatient visits every 3 mos.
Both groups received diabetes management, nutrition,
exercise, and blood glucose self-monitoring education.
To the visit: NA
Patient information: Intervention group uploaded glucose levels,
medications, BP and weight to web. Clinical instructors reviewed
information daily and sent recommendations every 2 weeks.
Medication changes referred to researcher and self-management
or lifestyle changes referred to nurse or dietitian.
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Table 6 Detailed information about interventions (Continued)
12 Cho et al. 2009 [66] On the schedule: NA NA
To the visit: NA
Patient information: Participants using diabetes phones transmitted
SMBG levels to web server automatically, received provider
messages via SMS.
Participants using internet entered SMBG levels on individual web
charts, used self-management program, communicated with
provider. Both groups received visual display graphs of data and
encouragement if no SMBG entered > 1 week.
13 Cho et al. 2011 [67] On the schedule: NA NA
To the visit: NA
Patient information: When patients visited the public healthcare
post, nurses measured blood glucose level with a PDA for both
intervention and control group. For the intervention group, the
glucose levels and other health information were uploaded to a
remote diabetes center; physicians at diabetes center performed
problem assessment and made recommendations for patients.
Nurses contacted the patients and educated intervention group
patients according to physician instruction.
14 Chumbler et al. 2005 [21] On the schedule: Care coordinator facilitated scheduling provider
appointment if necessary.
NA
To the visit: NA
Patient information: Intervention group used phone data line to
answer questions (symptoms, behavior, and knowledge). Patient
data downloaded to care coordinator’s desktop daily and patients
contacted via audio-visual conferencing.
15 Ciemins et al. 2009 [52] On the schedule: NA NA
To the visit: NA
Patient information: Diabetes registry integrated with EHR identified
diabetes patients prior to office visit, staff able to print patient
diabetes care summary sheet for provider, and patient report cards
for patients.
16 de Grauw et al. 2002 [19] On the schedule: Office assistant contact patients who do not
come in for visits at regular intervals.
Feedback at practice and physician level.
To the visit: NA
Patient information: Registry records process and outcome
measures from visits into EHR.
17 Derose et al. 2009 [25] On the schedule: NA NA
To the visit: Automated reminder system for patients with overdue
lab tests, included phone calls and/or letters. Interventions are: I.1
Letter, I.2 Letter-Call, I.3 Letter-Call-Letter, I.4 Call, I.5 Call-Letter
Patient information: NA
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Table 6 Detailed information about interventions (Continued)
18 Dijkstra et al. 2005 [54] On the schedule: NA NA
To the visit: NA
Patient information: Diabetes passport (PHR) summarizes personal
goals, medical or lab outcomes for each year.
19 Edelman et al. 2010 [34] On the schedule: Intervention groups with 7 to 8 patients meeting
every 2 months.
NA
To the visit: Received $10 for group visit attended for travel costs.
Patient information: Structured group interactions facilitated by
diabetes educator with pharmacist and physician adjusting
medications based on HbA1c and BP.
20 Edwards et al. 2012 [17] On the schedule: Patients are contacted by telephone to schedule
an appointment with a pharmacist in Diabetes Assessment Service
(DAS) approximately 1 week prior to the physician appointment.
NA
To the visit: NA
Patient information: Pharmacist completed the ADA standards of
care including measurement of HbA1c and fasting lipid panel
(total cholesterol, LDL, HDL, and triglycerides); a comprehensive
monofilament foot exam; administration of pneumococcal and
influenza vaccinations; collection of urine sample for screening for
microalbumin; referral for funduscopic eye exam; medication history
focusing on adherence to prescribed antidiabetic, antihypertensive,
and antihyperlipidemic medications and aspirin. The results of tests
and any pharmacotherapy recommendations are documented in
the patient’s EMR. The note is routed to the physician for review
prior to the next appointment.
21 Farmer et al. 2005 [68] On the schedule: NA Both groups given blood glucose monitor
To the visit: NA
Patient information: Both groups given mobile phone; SMBG levels,
food intake, insulin dose, and activity levels automatically
transmitted to server and made available to patient by web.
Intervention group received real time clinical advice and structured
counseling from diabetes specialist nurse.
22 Fischer et al. 2011 [13] On the schedule: Mailed patient report card reminding patient to
schedule appointment if≥ 2 mos since last provider visit.
NA
To the visit: NA
Patient information: Point-of-care patient report cards generated
automatically at visit (and mailed quarterly) included patient
performance compared to national targets. Medical assistants
encouraged patients’ self-management goals. Quarterly provider
performance report card generated from the registry.
23 Fischer et al. 2012 [69] On the schedule: NA The PRM system sends text messages to patients
automatically according to an established schedule, and
To the visit: Patients received text message appointment reminders
7, 3, and 1 days before appointments.
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Table 6 Detailed information about interventions (Continued)
processes responses for appropriate action based on
established threshold values.
Patient information: Patients received blood sugar reading requests
every Monday, Wednesday, and Friday. The fasting blood sugar
values outside the range of 70 to 400 mg/dL were automatically
flagged in PRM and routed to a work queue. A registered nurse
reviewed all flagged messages, contacted patients by telephone
for follow-up assessment, presented out-of-range values to a
physician, and ensured that both telephone encounters and
patient-reported blood sugar measurements were appropriately
documented in the medical record.
24 Glasgow et al. 2003 [70] On the schedule: NA Peer support
To the visit: NA
Patient information: All groups received information-based diabetes
self-management website providing coaching, resources and
graphical feedback based on transmitted SMBG levels and diet.
Peer information exchange, coping strategies, emotional support,
and 5 electronic newsletters.
25 Glasgow et al. 2004 [58] On the schedule: NA NA
To the visit: NA
Patient information: Diabetes Priority Program touchscreen
assessment and feedback completed. BP, cholesterol, feet exam,
microalbumin, dilated eye exam, dietary, physical activity, and
smoking behavior and self-management goals data entered creating
patient’s personalized action plan and summary of needed medical
procedures printout.
26 Grant et al. 2008 [55] On the schedule: NA Evaluate treatment intensification
To the visit: NA
Patient information: Intervention group used PHRs prior to visit with
ability to review and edit medications, self-management goals/
limitations, view laboratory results and generate diabetes care plan
electronically submitted to physician before next appointment.
27 Harno et al. 2006 [71] On the schedule: NA Home care link free of charge
To the visit: NA
Patient information: Intervention group downloaded SMBG levels
into regional database using modem. Self-management system
allowed diabetes team to transmit SMS test messages to patients’
mobile phones and internet access.
28 Holbrook et al. 2009 [28] On the schedule: NA NA
To the visit: Patients received monthly phone reminders for
medications and for laboratory and provider visits.
Patient information: Most recent laboratory results and other
diabetes risk factors (e.g., feet check, smoking and physical activity)
available to patient and provider at time of visit. Brief, prioritized
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Table 6 Detailed information about interventions (Continued)
messages of advice sent to patient by provider based on
automated risk analysis.
29 Hurwitz et al. 1993 [72] On the schedule: NA NA
To the visit: Database, which sends requests to patients to provide
laboratory testing (6 monthly prompt) and optometrist exam
(12 monthly prompt).
Patient information: Laboratory results incorporated into PHR, sent
to patients and request for provider within 10 days (elevated blood
glucose 3 days). Lack of feedback (including optometry) prompts
phone/letter reminder to provider and letter reminder to patient.
30 Jones and Curry 2006 [50] On the schedule: Reminder for recommended care based on
practice guidelines and scheduling for services (mailed quarterly).
NA
To the visit: NA
Patient information: Data entered into PDA at each visit: HbA1c,
hepatic enzymes, weight, systolic and diastolic BP, and date of
glucometer correlation. Clinical practice guideline
recommendations tracked: dates/results of last lipid panel,
nephropathy screen, eye exam, foot exam, last influenza and
pneumococcal vaccinations, last diabetes education, dietician
education, and smoking cessation education if needed. Reminder
of due or overdue guideline recommendations to provider at
each patient visit.
31 HS Kim et al. 2005 [44] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group entered SMBG values and
drug information to website. Nurse researcher reviewed entered
data and integrated EHR data (smoking habits, body mass index
(BMI), blood pressure (BP) and laboratory results), sending
recommendations to patient by SMS and internet. Medication
changes were communicated to patients’ providers. Education
provided and reinforcement of diet, exercise, foot care,
medication adjustment and self-management by SMS and internet.
If no patient self-monitored blood glucose (SBMG) data entered
on website for > 1 week, warning message was sent to patient
via internet.
32 HS Kim et al. 2006 [42] On the schedule: NA NA
To the visit: NA
Patient information: See H. Kim et al. 2005 [44] (Index # 31)
33, 34 HS Kim 2007 [39, 40] On the schedule: NA NA
To the visit: NA
Patient information: See H. Kim et al. 2005 [44] (Index # 31)
35 HS Kim and Jeong 2007 [41] On the schedule: NA NA
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Table 6 Detailed information about interventions (Continued)
To the visit: NA
Patient information: See H. Kim et al. 2005 [44] (Index # 31)
36 HS Kim and Song 2008 [43] On the schedule: NA NA
To the visit: NA
Patient information: See H. Kim et al. 2005 [44] (Index # 31)
37 SI Kim and HS Kim 2008 [73] On the schedule: NA NA
To the visit: NA
Patient information: See H. Kim et al. 2005 [44] (Index # 31)
38 Kirsh et al. 2007 [12] On the schedule: A letter is sent informing the patient that he/she
had suboptimal diabetes measures and inviting the patient to call
and make an appointment.
NA
To the visit: NA
Patient information: NA
39 Kwon et al. 2004 [74] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group entered SMBG levels,
medication, BP, weight, diet, exercise or hypoglycemic events on
web. Providers could review data e.g., past history, family history,
smoking, anthropometry, BMI, BP, and lab data. After integration
patient data, providers sent recommendations via individual EHR
and answered questions. Nurses reviewed lifestyle changes, exercise
and dietitians reviewed nutrition via EHR. If no patient SBMG data
entered on website for > 1 week, warning message sent via internet.
40 Kwon et al. 2004 [45] On the schedule: NA NA
To the visit: NA
Patient information: Participants entered SMBG levels, medication,
and hypoglycemic events on web. Patient questions about
medication, diet, and exercise posted through specialized electronic
chart on web. SMBG levels also sent using SMS. Providers sent
recommendations about medications according to SMBG. Dieticians
and nurses provided nutrition and exercise consults on web.
41 Lafata et al. 2002 [14] On the schedule: Letter from provider mailed to patient for birthday
with felicitations, advise routine appointments, screening and
laboratory tests, and a self-care handbook, and preventive care
checklist.
NA
To the visit: NA
Patient information: NA
42 Lin et al. 2007 [29] On the schedule: Intervention group scheduled for individual
30- minute appointments instead of default 15-minute appointments
every 3 mos. A secretary telephoned each patient before scheduled
NA
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Table 6 Detailed information about interventions (Continued)
appointment day to arrange for routine blood work one week before
the appointment.
To the visit: A secretary telephoned each patient before scheduled
appointment day as reminder of appointment, to bring medications
and SMBG log books.
Patient information: Standardize diabetic flow sheet according to
Canadian Diabetes Association’s guidelines used to record patient
information.
43 Litzelman et al. 1993 [75] On the schedule: NA Behavioral contract for desired foot-care
To the visit: NA
Patient information: Nurse-clinicians conducted educational sessions
covering foot-care behavior. Intervention group received postcard
reminder of desired foot-care behavior. Providers received
informational flow sheet providing patient-specific risk factors,
foot-care practice guidelines, diagnostic work-up, treatment and
referral recommendations.
44 Lorig et al. 2010 [76] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group utilized web diabetes
self-management program: ‘The Learning Center’ (educational
material), weekly queries for problems and to set action plan, a
‘Discussion Center’ (interactive, threaded), ‘Tools’ (exercise,
medication, meal planning and SMBG logs), ‘Post Office’ (private
email to facilitator, and ‘Help’ (also available by phone).
45 Maclean et al. 2009 [20] On the schedule: The Vermont Diabetes Information System (VDIS),
a lab based registry, sent provider faxed reminders and mailed
patient reminders for overdue lab tests.
NA
To the visit: NA
Patient information: Provider decision support with faxed lab results
flow sheets and mailed quarterly population reports for peer
comparisons. Mailed alerts for elevated test results.
46 McCarrier et al. 2009 [77] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group received 1-hour consultation
with nurse practitioner and 1:1 web module instruction. Website
allowed patient to view their EMR, enter SMBG values, trend daily
medication, nutrition, and exercise, create action plan, and use
educational resources.
47 McDermott et al. 2001 [32] On the schedule: NA NA
To the visit: Trained healthcare workers managing a paper-based
recall and reminder system for follow-up
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Table 6 Detailed information about interventions (Continued)
Patient information: Staff training in checking weight, BP, visual
acuity, feet, HbA1c, lipid level and urine for albumin to creatinine
ratio (ACR) and administration of vaccines.
48 McDiarmid et al. 2001 [51] On the schedule: NA NA
To the visit: Flashing reminder on check-in screen for patient to
complete Diabetes Questionnaire and Reminder sheet (DQR). DQR
directed patient attention to adherence to preventive care schedule
and recommendations.
Patient information: DQR reminded providers to update diabetic
flow chart and check feet. DQR directed patient attention to HbA1c,
recent blood sugars, and self-management issues.
49 McMahon et al. 2005 [78] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group received notebook
computer, glucose and BP monitoring devices and access to care
management website. Patients received educational resources,
uploaded information from monitoring devices and could internal
message the care manager using website.
50 McMahon et al. 2012 [47] On the schedule: NA NA
To the visit: NA
Patient information: Online care management (I.1): Patients are asked
to upload glucose and blood pressure monitoring data and
communicate securely with provider through patient portal;
Telephone care management (I.2): Patients received phone calls
bi-weekly to review glucose and blood pressure readings; Usual care
with web training (I.3): Patients had access to online training
materials that could be viewed at their discretion.
51 Mehler et al. 2005 [79] On the schedule: NA Provider education
To the visit: NA
Patient information: Providers urged to order lipid profiles for
intervention groups by direct detailing or electronic detailing,
reinforcing current lipid treatment guidelines and answering specific
hyperlipidemia treatment questions.
52 Meigs et al. 2003 [49] On the schedule: NA NA
To the visit: NA
Patient information: Disease Management Application (DMA) enables
decision support at time of patient contact, displays trended and
tabular electronic laboratory data interactively linked to
evidence-based treatment recommendations, aides workflow and
links to additional patient and provider care resources.
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Table 6 Detailed information about interventions (Continued)
53 Meulepas et al. 2007 [30] On the schedule: NA NA
To the visit: Diabetes Support Service (DSS) offered logistic support
to providers and called up patients for laboratory testing (repeated
3-monthly and annual), foot examination, fundus photography and
appointments with the dietician and diabetes nurse.
Patient information: Laboratory results sent to provider.
54 Meulepas et al. 2008 [31] On the schedule: NA NA
To the visit: DSS called patients for laboratory testing (repeated
3-monthly and annual), foot examination, fundus photography and
appointments with the dietician and diabetes nurse.
Patient information: Practice nurse reviewed information and gave
lifestyle advice to patient, traced risk factors and set short term goals
with patient during quarterly visits.
55 Moattari et al. 2013 [80] On the schedule: NA NA
To the visit: NA
Patient information: Patients are asked to enter their self-monitored
blood glucose level, kind and dose of insulin they used, and the
amount and kind of daily food intake to the website every day.
Healthcare team (physician, nurse, nutritionist) had access to
patient’s files. The care team answers patients’ questions through
the website and provides recommendations via email. Patients who
need immediate response can ask questions using phone or SMS.
56 Moorman et al. 2012 [81] On the schedule: NA NA
To the visit: NA
Patient information: Patients were provided with a blank SMBG log
at provider appointment in a pharmacist-run diabetic clinic and
asked to return the completed log after two weeks via mail, fax, or
telephone communication. Those patients in the post intervention
cohort were sent reminder mailings one week before logs were due.
57 Musacchio et al. 2011 [82] On the schedule: NA NA
To the visit: NA
Patient information: Diabetologists, nurses and dietitians empower
patient self-management, using patient clinic history in their EHR.
Phone and internet utilized for patient communication.
58 Nes et al. 2012 [83] On the schedule: NA NA
To the visit: NA
Patient information: Patients were given access to web-based diaries
housed on a secure server where they (1) registered their fasting
blood glucose level in the morning, and eating behavior,
medication compliance, exercise, and emotions three times per day;
(2) received individualized situational feedback based on acceptance
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Table 6 Detailed information about interventions (Continued)
and commitment therapy; and (3) had access to mindfulness and
relaxation exercises via audio file.
59 Piette et al. 2000 [84] On the schedule: NA NA
To the visit: NA
Patient information: Biweekly automated assessment calls to patients
regarding: SMBG levels, symptoms, foot problems, chest pain,
breathing problems, self-care problems. Nurse educator reviewed
information and prioritize patients. Follow-up calls to discuss the
reported problems, strategies for resolution, and education about
importance of self-care, health monitoring, weight control, nutrition,
and exercise.
60 Rai et al. 2011 [18] On the schedule: Automated outreach communication message to
proactively motivate patients to schedule appointments.
NA
To the visit: NA
Patient information: NA
61 Ralston et al. 2009 [38] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group utilized web-based program
to review online medical record, upload SMBG levels, create action
plan, and exchange secure email with care manager. Care manager
reviewed patient action plans, SMBGs and laboratory results at least
1×/week, adjusted hypoglycemic medications, guided patient health
behavior, self-management support, and conferred with provider.
Web program provided single-page summary of patient clinical
diabetes information.
62 Ryan et al. 2013 [85] On the schedule: NA Participants were given desktop computer, glucometer and
test strips, Internet connection at home, periodic refresher
training, and telephone user support.To the visit: NA
Patient information: Patients are asked to upload blood sugar levels
and log into diabetes relationship management package. The web-
based application provides educational material and motivational
messages; access to providers for education, communication, and
peer networking; chat with registered nurses. Nurses can view
patients’ electronic medical records while chatting with patients.
63 Sacco et al. 2009 [48] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group received weekly phone
coaching for goal setting and self-management, SMBG testing,
medication, nutrition, exercise, foot care, stress management, eye
exam, dental care, and vaccinations.
64 Sadur et al. 1999 [22] On the schedule: Scheduled 2 hour cluster visits involving 10–18
patients every month for 6 mos.
NA
To the visit: NA
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Table 6 Detailed information about interventions (Continued)
Patient information: Intervention group received multidisciplinary
care managed by diabetes nurse educator, two diabetologists,
dietitian, behaviorist, and pharmacist. Nurse reviewed self-
management by telephone twice monthly to every 3 days.
65 Seto et al. 2012 [16] On the schedule: Patients are contacted by telephone to
schedule follow-up appointments.
Cost-benefit analysis of implementing and maintaining the
registry
To the visit: Reminder phone calls are made 24 h before the
appointment. For the patients who did not return, the medical
assistants called the patients or sent them a letter inquiring about
access barriers.
Patient information: NA
66 DM Smith et al. 1987 [27] On the schedule: NA Mailed educational booklet
To the visit: Intervention group was mailed billfold-sized card with
their provider and nurse name, clinic location, office hours, and
telephone number, and single-page description on how to use
card for appointments, medication refills and health problems
with information of diabetic warning signs. Patient received a
postcard reminder a week before each scheduled return visit. If
patient missed an appointment intense follow-up by telephone
and letter was implemented until another visit scheduled.
Patient information: NA
67 KE Smith et al. 2004 [86] On the schedule: Intervention group scheduled for baseline, 3 mos
and 6 mos visits as routine care.
NA
To the visit: NA
Patient information: Intervention group entered SMBG values,
exercise logs, and communicated with provider via Web-based
diabetes management application (MyCareTeam).
68 Song et al. 2009 [87] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group utilized website with public
space with diabetes self-management information, secure space to
download SMBG values, calculator of daily caloric intake, physical
activity log, stress measurement, feedback from specialist and FAQ
area.
69 Stone et al. 2012 [88] On the schedule: NA NA
To the visit: NA
Patient information: (I.1) Active care management to lower intensity
care coordination (ACM-to-CC), (I.2) Active care management to care
coordination with continued home telemonitoring (ACM-to-CCHT),
(I.3) Care coordination to continued care coordination (CC-to-CC),
(I.4) Care coordination to usual care (CC-to-UC). Care coordination
includes monthly educational phone calls, and home telemonitoring
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Table 6 Detailed information about interventions (Continued)
includes daily transmission of blood glucose, blood pressure, and
weight.
70 Subramanian et al. 2009 [23] On the schedule: OA clinics offered same-day scheduling for patients. NA
To the visit: NA
Patient information: NA
71 Tang et al. 2013 [89] On the schedule: NA NA
To the visit: NA
Patient information: The interventions included: i) wireless upload
of home glucometer readings to EHR, ii) comprehensive patient-
specific diabetes summary status report which includes patient’s
personalized action plan and treatment goals, diabetes
complications risk, monitoring tests, medications, and health
maintenance schedule, iii) nutrition and exercise logs, iv) insulin
record; v) online messaging with the patient’s healthcare team,
vi) nurse care manager and dietitian providing timely advice and
medication management, and vii) personalized educational text and
videos dispensed electronically by the care team. Primary care
physicians were kept up to date about clinical changes through the
shared EHR.
72 Thomas et al. 2007 [26] On the schedule: NA NA
To the visit: Letters recommending appropriate surveillance tests
automatically sent quarterly to patient without HbA1c within 6 mos
or LDL within 12 mos.
Patient information: Audit, feedback and patient reminder
intervention utilized computerized diabetes registry to provide
physicians with patient information.
73 Tildesley et al. 2010 [90] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group uploaded SMBG levels every
2 weeks to web. Web-based system used to input medications, set
alarms, view summary of SMBG levels, and send message to
endocrinologist. Endocrinologist views data and, sends orders for
insulin dosage and test frequency. Patients asked to perform
laboratory test and visit endocrinologist every 3 mos.
74 Weber et al. 2008 [53] On the schedule: NA Monetary incentive to providers for improvements in
meeting evidence-based guidelines.
To the visit: NA
Patient information: Assess ADA standards of care with EHR (EPIC).
Intervention included health maintenance alerts to provider, best-
practice-alerts, and nurse rooming tool.
75 Yeh et al. 2006 [33] On the schedule: NA NA
To the visit: Patient-Oriented education management system for
diabetes using the Internet (POEM) sent reminders to intervention
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Table 6 Detailed information about interventions (Continued)
group 1 week before follow-up visit, HbA1c test period if more than
3 mos, and emergency calls for abnormal laboratory test results
using emails and SMS.
Patient information: System automatically download patient’s
records, prescriptions, laboratory test results, patient education
materials and organizes into case folders based on patients’ medical
service history from hospital for provider use at outpatient visit.
76 Yoo et al. 2009 [91] On the schedule: NA NA
To the visit: NA
Patient information: Phone reminder is used to remind patient to
measure blood glucose and BP twice a day. Device attached to
cellphone conducts glucose measurements and automatically sends
the results to a central database. Automated messages of
encouragement, reminders and recommendations are sent back to
patients. SMS is used to receive exercise time and send information
on healthy diet and exercise methods. Website is used to follow the
blood glucose levels, blood pressure, and weight changes, and send
individualized recommendations to patients when needed.
77 Yoon and HS Kim 2008 [92] On the schedule: NA NA
To the visit: NA
Patient information: Intervention group accessed website by cellular
phone or wired internet sending SMBG values and drug information.
Patient information automatically displayed on individual electronic
chart on homepage. Patients could view recommendations from
provider and laboratory test results. Recommendations sent to
patient weekly, by SMS through cellular phone and wired internet.
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Table 7 Changes in other clinical outcomes
Author On schedule To visit With information LDL (mg/dL) SBP (mm/Hg) Total cholesterol (mg/dL) Triglycerides (mg/dL) Other
Int Con p Int Con p Int Con p Int Con p
39 Kirsh et al. 2007 [12] ✓ −16 −5.4 0.29 −14.8 −2.5 0.04
70 Subramanian et al. 2009 [23] ✓ −6 −4 NS 1 −2 ≤0.05
5 Benhamou et al. 2007 [63] ✓ Glycaemia
6 Bond et al. 2006 [64] ✓ BS
7 Bond et al. 2007 [36] ✓ −6.8 −1 ≤.010 −11.4 −5.1 ≤.050 HDL
Wt
DBP
8 Carter et al. 2011 [37] ✓ −7 −8 NS BMI
Wt
DBP
12 Cho et al. 2009 [66] (phone) ✓ NP NA NS NP NA NS NP NA NS FPG
2HPMG
HDL
Cho et al. 2009 [66] (internet) ✓ NP NA NS NP NA NS NP NA NS FPG
2HPMG
HDL
13 Cho et al. 2011 [67] ✓ −0.2c NA .043 −0.5c NA NS FBG
HDLNA 0.1c NS NA −0.3c NS
Liver enzymes
18 Dijkstra et al. 2005 [54] ✓ 1.1 −0.2 NS -0.2c −0.2c NS DBP
CR
24 Glasgow et al. 2003 [70] (overall) ✓ −8.3 NA ≤.010 −11.7 NA ≤.010 −16.5 NA ≤.001 Lipid ratio
HDL
Glasgow et al. 2003 [70]
(peer support)
✓ Lipid ratio
Glasgow et al. 2003 [70]
(tailored self-management)
✓ Lipid ratio
26 Grant et al. 2008 [55] ✓ NP NP NS Blood pressure
Appendix 2
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Table 7 Changes in other clinical outcomes (Continued)
27 Harno et al. 2006 [71] ✓ −0.18c 0.11c NP 1 1 NP −0.21c 0.12c NP −0.05c 0.21c NP DBP
FBG
BMI
HDL
CR
32 HS Kim et al. 2005 [44]
“Effects of an Internet-based
Intervention…”
✓ −13.50 NA NS 27.30 NA NS FPG
2HPMG
HDL
34 HS Kim 2007 [39]
“A randomized controlled trial
of a nurse short-message service…”
✓ 2HPMG
FPG
35 HS Kim 2007 [40] “Impact of
web-based nurse’s education…”
✓ FPGd
2HPMG
36 HS Kim and H. Jeong 2007 [41]
“A nurse short message service
by cellular phone…”
✓ 2HPMG
FPG
37 HS Kim and M. Song 2008 [43]
“Technological intervention for
obese patients with type 2 diabetes”
✓ −5.1 9.9 0.04 4.5 40.8 0.62 FPG
2HPMG
HDL
38 SI Kim and HS Kim 2008 [73]
“Effectiveness of mobile and
internet intervention…”
✓ 2HPMG
FPG
39 Kwon et al. 2004a [74] ✓ −0.9 NA NS −24.4 NA ≤.007 HDL
FPG
40 Kwon et al. 2004b [45] ✓ −1.93 NA NS −3.33 NA NS −19.5 NA NS HDL
NA 1.88 NS NA 7.3 NS NA 13.5 NS FBG
49 McMahon et al. 2005 [78] ✓ −6 −5 NS −10 −7 ≤0.01 −38 NA ≤0.01 DBP
NA −2 NS HDL
50 McMahon et al. 2012 [47]
(online care)
✓ −4.0 NA 0.29 −0.3 NA 0.89 −7.8 NA 0.07 −25.5 NA 0.01 DBP
HDL
Wt
BMI
McMahon et al. 2012 [47]
(telephone care)
✓ −5.5 NA 0.12 −6.7 NA .006 −8.5 NA 0.05 −6.5 NA 0.68 DBP
HDL
Wt
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Table 7 Changes in other clinical outcomes (Continued)
BMI
McMahon et al. 2012 [47]
(usual care with web training)
✓ 5.8 NA 0.12 −3.1 NA 0.30 −10.7 NA 0.02 −26.4 NA 0.08 DBP
HDL
Wt
BMI
52 Meigs et al. 2003 [49] ✓ −14.7 −9.4 0.30 0.8 −2.2 0.03 DBP
55 Moattari et al. 2013 [80] ✓ −8.2 5.1 <0.02 3.9 −0.8 0.69 45.3 −7.9 0.34 HDL
FBS
61 Ralston et al. 2009 [38] ✓ NP NP NS NP NP NS DBP
62 Ryan et al. 2013 [85] ✓ −15.7 NA 0.10 4.4 NA 0.30 −15.5 NA 0.14 21 NA 0.01 DBP
HDL
BMI
67 KE Smith et al. 2004 [86] ✓ −18 NA NS −6 NA NS −25 NA NS −9 NA NS BMI
DBP
HDL
68 Song et al. 2009 [87] ✓ FBG
71 Tang et al. 2013 [89] ✓ −6.1 0.0 .001 −7.1 −5.3 NS Wt
DBP
Framingham
cardiovascular risk
73 Tildesley et al. 2010 [90] ✓ NP NP S NP NP S
76 Yoo et al. 2009 [91]
“A ubiquitous chronic disease
care system using cellular
phones and the internet”
✓ −0.4c −0.1c 0.03 −0.5c 0.0c 0.01 Wt
BMI−0.4c NA ≤.001 −7 NA ≤.001 −0.5c NA ≤.001 −0.22c NA ≤.003
DBP
HDLNA −0.1c NS NA −4.00 NS NA 0.0c NS NA 0.08c NS
77 Yoon and HS Kim 2008 [92] ✓ −3.1a 29.3a 0.18 −31.1a 52.3a 0.28 2HPMG
HDL
FPG
4 Bailie et al. 2004 [62] ✓ ✓ 66e NA NS DBP
0a NA NS
11 Cho et al. 2006 [57] ✓ ✓ −0.14ac −0.31ac NS −0.08ac 0.4ac ≤.050 HDL
FBG
CR
16 de Grauw et al. 2002 [19] ✓ ✓ −3 NA 0.20 −31 NA ≤.001 −41 NA ≤.001 HDL
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Table 7 Changes in other clinical outcomes (Continued)
FBG
DBP
30 Jones and Curry 2006 [50] ✓ ✓ −2.5 −5.3 NS −1.1 −0.7 NS DBP
−2.5 NA NS −1.1 NA NS Wt
NA −5.3 0.03 NA −0.7 NS
45 MacLean et al. 2009 [20] ✓ ✓ −12.5 −13.6 NS BMI
DBP
28 Holbrook et al. 2009 [28] ✓ ✓ −0.05c 0.02c NS −4.7 0.3 0.04 DBP
BMI
Alb
29 Hurwitz et al. 1993 [72] ✓ ✓ RPG
53 Meulepas et al. 2007 [30] ✓ ✓ −5 4 ≤.050 −0.4c −0.3c NS −0.1c 0.1c NS FBG
DBP
54 Meulepas et al. 2008 [31] ✓ ✓ 4 5 NS −0.3c −0.3c NS −0.3c −0.3c NS FBG
BMI
DBP
72 Thomas et al. 2007 [26] ✓ ✓ −4.9 −4 0.61 −0.5 NA NS DBP
NA 1.7 NS
75 Yeh et al. 2006 [33] ✓ ✓ −24 −22 ≤.050 FBG
19 Edelman et al. 2010 [34] ✓ ✓ ✓ −13.7a −6.4a 0.01 DBP
42 Lin et al. 2007 [29] ✓ ✓ ✓ −0.59c NA <0.01 −4.7 NA NS DBP
WtNA −0.16c NS NA 1 NS
Int intervention, Con Control, NA not Applicable, NS non-significant (p-value>0.05), S significant (p-value≤0.05), NP not provided
Results are differences in mean before and after implementation of intervention except those indicated with the following superscripts
aMultiple measurements are presented over time after the intervention in the paper, but the last measurement is used to calculate the difference in this table
bMultiple measurements are presented over time after the intervention in the paper, but median change is reported
cUnit is mmol/l
dHbA1c<7 at baseline
e% with BP < 140/90
Other outcome measures include: DBP Diastolic blood pressure, CR Creatinine, Wt Weight, FPG Fasting plasma glucose, FBG Fasting blood glucose, FBS Fasting blood sugar, BS Blood sugar, 2HPMG 2-hour post-meal glucose,
FBG Fasting blood glucose, RPG Random plasma glucose, Alb Albuminuria
Bolded text in ‘Other’ category indicates significant finding
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Table 8 Changes in behavioral outcomes
Author On schedule To visit With information Improved self-management
SMBG testing Self-efficacy
score
QOL score Patient
satisfaction
Physical activity
exercise
Foot care Diet Nutrition
1 Anderson et al. 2003 [15] ✓
41 Lafata et al. 2002 [14] ✓
60 Rai et al. 2011 [18] ✓
70 Subramanian et al. 2009 [23] ✓
2 Austin and Wolfe 2011 [24] ✓
17 Derose et al. 2009 [25] ✓
66 DM Smith et al. 1987 [27] ✓
3 Avdal et al. 2011 [61] ✓
5 Benhamou et al. 2007 [63] ✓ NS S
8 Carter et al. 2011 [37] ✓ NS NS
10 Cherry et al. 2002 [46] ✓ S NS
12 Cho et al. 2009 [66]
(internet vs. phone)
✓ NSb NSa
13 Cho et al. 2011 [67] ✓ S
15 Ciemins et al. 2009 [52] ✓
18 Dijkstra et al. 2005 [54] ✓
24 Glasgow et al. 2003
(overall) [70]
✓ NS S
Glasgow et al. 2003
(peer support) [70]
✓ NS NS
Glasgow et al. 2003
(tailored self-management) [70]
✓ NS S
25 Glasgow et al. 2004 [58] ✓ S NS S S
32 HS Kim et al. 2005 [44] ✓ S
33 HS Kim et al. 2006 [42] ✓ S S NS
40 Kwon et al. 2004 [45] ✓ A
43 Litzelman et al. 1993 [75] ✓ S
44 Lorig et al. 2010 [76] ✓ S NS
46 McCarrier et al. 2009 [77] ✓ S
Appendix 3
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Table 8 Changes in behavioral outcomes (Continued)
50
McMahon et al. 2012 [47]
(online care) ✓
McMahon et al. 2012 [47]
(telephone care)
✓
McMahon et al. 2012 [47]
(usual care with web training)
✓
51 Mehler et al. 2005 [79] ✓
52 Meigs et al. 2003 [49] ✓
56 Moorman et al. 2012 [81] ✓ NS
57 Musacchio et al. 2011 [82] ✓
58 Nes et al. 2012 [83] ✓ NP
59 Piette et al. 2000 [84] ✓ S NS S
62 Ryan et al. 2013 [85] ✓ NS
63 Sacco et al. 2009 [48] ✓ S S S S
68 Song et al. 2009 [87] ✓
71 Tang et al. 2013 [89] ✓ S
74 Weber et al. 2008 [53] ✓
76 Yoo et al. 2009 [91] ✓ NP
65 Seto et al. 2012 [16] ✓ ✓
4 Bailie et al. 2004 [62] ✓ ✓
14 Chumbler et al. 2005 [21] ✓ ✓
16 de Grauw et al. 2002 [19] ✓ ✓
20 Edwards et al. 2012 [17] ✓ ✓
22 Fischer et al. 2011 [13]
(mailed patient report card)
✓ ✓
30 Jones and Curry 2006 [50] ✓ ✓
45 MacLean et al. 2009 [20] ✓ ✓ NS S NS NS
64 Sadur et al. 1999 [22] ✓ ✓ NS NS NS NS NS S
23 Fischer et al. 2012 [69] ✓ ✓ S A
28 Holbrook et al. 2009 [28] ✓ ✓ NS
47 McDermott et al. 2001 [32] ✓ ✓
48 McDiarmid et al. 2001 [51] ✓ ✓
53 Meulepas et al. 2007 [30] ✓ ✓
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Table 8 Changes in behavioral outcomes (Continued)
54 Meulepas et al. 2008 [31] ✓ ✓ S
72 Thomas et al. 2007 [26] ✓ ✓
19 Edelman et al. 2010 [34] ✓ ✓ ✓
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Table 8 Changes in behavioral outcomes (Continued)
Author Increased outpatient care servicesa Decreased acute care
utilization
Improved adherence to ADA guidelines Other
Lab tests
completed
Vaccination Provider
visit
Specialist
visit
Emergency
visits
Hospital
admissions
Foot
exam
Eye exam Processes of care
1 Anderson et al. 2003 [15] S
41 Lafata et al. 2002 [14] A1c S S
LDL
60 Rai et al. 2011 [18] A1c S
70 Subramanian et al. 2009 [23] A1c↓ NS NS NS
LDL
Alb↓
2 Austin and Wolfe 2011 [24] A1c
LDL
17 Derose et al. 2009 [25] A1c
LDL
Alb
66 DM Smith et al. 1987 [27] S NS Kept scheduled visits↑
Scheduled appointments↑
Missed appointments
Medication refills
3 Avdal et al. 2011 [61] S
5 Benhamou et al. 2007 [63]
8 Carter et al. 2011 [37] Diabetes knowledge↑
Diabetes management practice↑
Perceived physical health status↑
Perceived mental health status↑
10 Cherry et al. 2002 [46] S↓ NS NS Patients who feel more connected
Medication compliance
Number of post-discharge visits
12 Cho et al. 2009 [66]
(internet vs. phone)
13 Cho et al. 2011 [67]
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Table 8 Changes in behavioral outcomes (Continued)
15 Ciemins et al. 2009 [52] A1c S S S
LDL
Lip
AlbCR
18 Dijkstra et al. 2005 [54] A1c NS S NS Urine exam < 12 mo.
TC Weight checked
BP BMI checked
Physical exercise advised↑
Smoking discussed↑CR
24 Glasgow et al. 2003
(overall) [70]
S Psychosocial outcomes (total support scale)↑
Glasgow et al. 2003
(peer support) [70]
NS Psychosocial outcomes (total support scale)↑
Glasgow et al. 2003
(tailored self-management) [70]
NS Psychosocial outcomes (total support scale)
25 Glasgow et al. 2004 [58] BP S S Self-management goal setting↑
Alb Depressive symptoms
32 HS Kim et al. 2005 [44]
33 HS Kim et al. 2006 [42] Medication taking↑
40 Kwon et al. 2004 [45]
43 Litzelman et al. 1993 [75] S
44 Lorig et al. 2010 [76] NS Health distress↓
Depression
Patient activation
46 McCarrier et al. 2009 [77] Program usage
50
McMahon et al. 2012 [47]
(online care)
Diabetes distress
McMahon et al. 2012 [47]
(telephone care)
Diabetes distress
McMahon et al. 2012 [47]
(usual care with web training)
Diabetes distress
51 Mehler et al. 2005 [79] LDL
Lip
52 Meigs et al. 2003 [49] A1c S NS
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Table 8 Changes in behavioral outcomes (Continued)
LDL
56 Moorman et al. 2012 [81] Follow up appointment kept
Returned SMBG log
57 Musacchio et al. 2011 [82] S↓
58 Nes et al. 2012 [83] Diabetes distress
59 Piette et al. 2000 [84] Depression↓
Days in bed because of illness↓
Anxiety
62 Ryan et al. 2013 [85]
63 Sacco et al. 2009 [48]
68 Song et al. 2009 [87] Diabetes care knowledge↑
Diabetes care behavior↑
71 Tang et al. 2013 [89] NS Diabetes distress
74 Weber et al. 2008 [53] A1c In S Percentage documented non-smoker
PnLDL
Alb
76 Yoo et al. 2009 [91]
65 Seto et al. 2012 [16] A1c Appointment adherence
4 Bailie et al. 2004 [62] A1c In S S Weight measurement↓
CR Pn BMI measurement
AlbCR Counseling about diet, activity, weight, smoking,
alcohol, medication
Lip
14 Chumbler et al. 2005 [21] S NS S S NS NS
16 de Grauw et al. 2002 [19] A1c S S
SBP
DBP
20 Edwards et al. 2012 [17] A1c In S S S
Lip Pn
22 Fischer et al. 2011 [13]
(mailed patient report card)
A1c
BP
LDL
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Table 8 Changes in behavioral outcomes (Continued)
30 Jones and Curry 2006 [50] In S S
Pn
45 MacLean et al. 2009 [20] A1c S↓ S↓ S S Functional status
Blood testingLDL
Cost↓CR
64 Sadur et al. 1999 [22] NS S
23 Fischer et al. 2012 [69] No-shows
Cancellations
28 Holbrook et al. 2009 [28] A1c S S S
BP
LDL
Alb
47 McDermott et al. 2001 [32] A1c In S S S Hypertension receiving treatment,
BP Pn Retinopathy noted,
Dyslipidemia noted↑,
Self monitoring,
Urinary ACR checked <12 mo.↑,
Weight checked↑,
BP checked ↓,
Lip Albuminuria on ACE inhibitor treatment
CR
48 McDiarmid et al. 2001 [51] A1c S S Office visit with inquiry of hypoglycemia↑
LDL
Alb
53 Meulepas et al. 2007 [30] A1c S S Smoking status checked↑,
BP BMI checked↑
FBG
DBP
TC
CR
54 Meulepas et al. 2008 [31] Percentage of non-smokers,
BMI checked
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Table 8 Changes in behavioral outcomes (Continued)
72 Thomas et al. 2007 [26] A1c
LDL
19 Edelman et al. 2010 [34] S↓ S NS Lightheadedness or falls↓,
Medication adherence
S significant (p-value≤0.05), NS non-significant (p-value>0.05), ↓ decrease, ↑ increase
aIf outpatient care services are significantly reduced (not increased) after intervention, it is represented using ↓
A1c Hemoglobin HbA1c test, SBP Systolic blood pressure, DBP Diastolic blood pressure, BP Blood pressure, CR Creatinine, TC Total cholesterol, FBG Fasting blood glucose, Alb Urine microalbumin, AlbCR Microalbumin/
creatinine, BMI Body mass index, Lip Lipid profile, In Influenza vaccination, Pn Pneumonia vaccination
Bolded text indicates significant findings
bDifference between groups, A Measured only after the intervention, NP p-value is not given
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